Acceso y uso de los foros

Saladrigas, M.V., Navarro, F.A., Gómez Polledo, P., Munoa, L. (2021). Glosario de covid-19 (EN-ES). Tremédica-Cosnautas. <https://www.tremedica.org/tremediteca/glosarios/glosario-de-covid-19-en-es/>

Aporte y traducción de ejemplos para el Glosario de covid-19 (EN-ES): Ana Atienza, Lida Barbetti, Inmaculada Caracuel, Iolanda Casacuberta, Rossana Couto, Ana Durán, Nur Ferrante, Lorenzo Gallego, María Hernández, Mar Jiménez, Raquel Lázaro, Roser Mas, Laura Pruneda, María Ruíz, Susana Sánchez, Rosario Sanz, Nora Torres y Teresa Triana.

Maquetación, ilustración, revisión y publicación electrónica del Glosario de covid-19 (EN-ES) abreviado en línea, respectivamente: Jorge de Buen (Imprimátvr), Marta Morón, Alejandro García-Aragón, Valentina Luridiana

María Verónica Saladrigas es doctora en ciencias biológicas con especialidad en biología molecular (Universidad de Buenos Aires, 1993), con veintiséis años de experiencia como traductora y revisora técnica o médica (inglés o francés>español) para organismos internacionales y laboratorios farmacéuticos, veintitrés de los cuales los ha desempeñado en el Departamento de registro farmacéutico de Novartis Pharma AG en Suiza, donde actualmente dirige el equipo de traducción EN>ES para Hispanoamérica. Miembro de MedTrad y socia cofundadora de Tremédica. Es autora del Glosario inglés-español de investigación clínica de la plataforma Cosnautas. Cofundadora de la revista Panace@ y actual miembro de su Consejo editorial.

Fernando A. Navarro es licenciado en medicina (Universidad de Salamanca, 1986) y especialista en farmacología clínica (Hospital Marqués de Valdecilla, 1991), con treinta y dos años de experiencia como traductor médico autónomo para laboratorios farmacéuticos, organismos internacionales y empresas del sector biosanitario. Socio de honor de Tremédica, Asetrad, IAPTI y UniCo. Es autor del Glosario de dudas y dificultades de traducción del inglés médico, del Repertorio de siglas médicas en español y del Gran glosario médico alemán-español, todos en la plataforma Cosnautas. Cofundador y primer director de la revista Panace@.

Paz Gómez Polledo es licenciada en medicina y cirugía (Universidad Complutense de Madrid, 1983), diplomada en medicina del trabajo (Escuela Nacional de Medicina del Trabajo, 1987) y doctora en medicina (UCM, 1989). Ha ejercido como cirujana en hospitales de Madrid, médica general en centros de atención primaria, médica forense interina en el Instituto de Medicina Legal de Alicante y médica de empresa en el Ayuntamiento de Alicante. Es traductora médica autónoma inglés>español desde hace 34 años, revisora y redactora de textos médicos y farmacéuticos en español, así como docente y autora de un blog sobre traducción médica. Es socia cofundadora de Tremédica, Asetrad, Medtrad y UniCo, y socia de las asociaciones de redactores médicos europea (EMWA) y española (AERTeM). Forma parte del consejo editorial de la revista Panace@.

Laura Munoa es licenciada en medicina (Universidad de Salamanca, 1982) y traductora autónoma para editoriales, laboratorios farmacéuticos, organismos internacionales y empresas del sector biosanitario desde 1989. Es miembro de MedTrad y socia cofundadora de Asetrad y Tremédica. Fue subdirectora de la revista Panace@, a cuyo consejo editorial pertenece, y es recopiladora del Árbol de Cos, colección de enlaces sobre lenguaje médico publicada en la plataforma Cosnautas.

A los siguientes miembros de Tremédica y Cosnautas, que han respaldado la iniciativa y colaborado desde el inicio en el proyecto: Javier Orellana, Alberto Roca, Álvaro Villegas, José Antonio de la Riva Fort.

A los siguientes profesionales y miembros de Tremédica, que han aportado y traducido muchos de los ejemplos que complementan algunos lemas: Ana Atienza, Lida Barbetti, Inmaculada Caracuel, Iolanda Casacuberta, Rossana Couto, Ana Durán, Nur Ferrante, Lorenzo Gallego, María Hernández, Mar Jiménez, Raquel Lázaro, Roser Mas, Laura Pruneda, María Ruíz, Susana Sánchez, Rosario Sanz, Nora Torres y Teresa Triana.

A Pilar Castillo Bernal, directora de la revista Panace@, y al equipo panaceico que hicieron posible la publicación del Glosario de covid-19 (EN-ES) abreviado, como suplemento de Panace@, en enero de 2021: Jorge de Buen (Imprimátvr, maquetación), Marta Morón (ilustradora), Alejandro García-Aragón (revisión), Valentina Luridiana (publicación electrónica).

A los profesionales sanitarios y al personal esencial del mundo, especialmente los caídos en actos de servicio durante la pandemia mundial.

A todas las empresas comprometidas en la lucha contra la covid-19.

A las editoriales que han puesto a disposición libros y revistas de forma gratuita para que los profesionales sanitarios, investigadores, divulgadores científicos, traductores e intérpretes tengan acceso a la información que necesitan en la lucha contra la coronavirosis.

A todos aquellos que con sus actos altruistas y sentido del humor nos han alegrado las interminables horas de confinamiento.

El Glosario de covid-19 (EN-ES) se publicó por primera vez en formato electrónico a principios de mayo de 2020 con el apoyo de Tremédica, que ofreció su cibersitio para albergarlo, y de Cosnautas, que se ocupó de los detalles técnicos de la puesta en línea. El objetivo de su elaboración fue recoger y ordenar la terminología básica relacionada con la covid-19 en inglés y proponer equivalentes en español meditados como ayuda práctica para los traductores, intérpretes, redactores, periodistas y divulgadores científicos que deben traducir y difundir información de calidad sobre el tema.

En su primera versión (v. 1.01) reunía más de 3200 lemas relacionados con los aspectos médicos, moleculares, virológicos, farmacológicos, económicos y sociales de la covid-19, de su agente etiológico SARS-CoV-2 y de los coronavirus en general. Un buen número de ellos abordaban los diversos tipos de máscaras y mascarillas. El glosario también incluía algunos neologismos y frases muy populares en las redes sociales en aquellos momentos de la pandemia.

En su versión actual (v. 1.16, de enero de 2021) contiene 5736 lemas en total, de los cuales la mayoría se refieren a conceptos virológicos, escalas, vacunas, pruebas diagnósticas y productos sanitarios relacionados con la covid-19, que complementan el lemario anterior o se han añadido a raíz de las consultas recibidas. Se trata de un glosario fraseológico, con notas de uso e información conceptual. Una selección del lemario se ha publicado recientemente en la revista Panace@ como suplemento y el pdf respectivo se puede descargar de forma gratuita en el cibersitio de Tremédica: https://www.tremedica.org/wp-content/uploads/panacea20-51_sup_glosario_covid-19.pdf.

Entre mayo y enero de 2021 el glosario ha recibido unas 42.186 visitas en la página de Tremédica. Esperamos que este proyecto conjunto de Tremédica y Cosnautas siga siendo de utilidad para el lector.

Los lectores pueden remitir sus comentarios y sugerencias a la dirección siguiente:  glosario.covid19@gmail.com.

Nota: Esta bibliografía está sujeta a actualización periódica.

I. FUENTES DE CONSULTA FRECUENTE

A. Especializadas

1. Diccionarios y otras fuentes lingüísticas

Cammack, R., Atwood, T., Campbell, P., Parish, H., Smith, A., Vella, F., y Stirling, J. (2008). Oxford Dictionary of Biochemistry and Molecular Biology (2ª ed.). Oxford University Press. https://dx.doi.org/10.1093/acref/9780198529170.001.0001

Igea Aznar, J. M. Alergología e inmunología. Diccionario inglés-español de alergología e inmunología clínica (3ª ed., versión 3.02; marzo de 2016). Cosnautas. https://www.cosnautas.com/es/alergologia

International Union of Biochemistry and Molecular Biology. (s. f.). Recommendations on Biochemical and Organic Nomenclature, Symbols and Terminology, etc. https://www.qmul.ac.uk/sbcs/iubmb/

Munoa, L. (comp.). Árbol de Cos. Colección de enlaces para la traducción y la redacción médicas. (versión 1.13; agosto de 2018). Cosnautas. http://www.cosnautas.com/es/arbol

Navarro, F. A. Diccionario de dudas y dificultades de traducción del inglés médico (Libro rojo) (3ª ed., versión 3.15; marzo de 2020). Cosnautas. https://www.cosnautas.com/es

Navarro, F. A. Siglas médicas en español. Repertorio de siglas, acrónimos y símbolos utilizados en los textos médicos en español (2ª ed., versión 2.21; enero de 2020). Cosnautas. https://www.cosnautas.com/es/siglas

Real Academia de Ciencias Exactas, Físicas y Naturales. (s. f.). VCTRAC digital. https://vctrac.es/index.php?title=P%C3%A1gina_principal

Real Academia Nacional de Medicina. (2012). Diccionario de términos médicos. http://dtme.ranm.es/index.aspx

Saladrigas Isenring, M. V. Diccionario inglés-español de investigación clínica (DIC) (1ª ed., versión 1.04; enero de 2019). Cosnautas. https://www.cosnautas.com/es/dic

2. Bases de datos

Drug Bank (https://www.drugbank.ca/)

MedNet (https://mednet-communities.net/inn)

PubChem (https://pubchem.ncbi.nlm.nih.gov/)

UniProt KB (https://www.uniprot.org/)

B. Generales

1. Diccionarios y otras fuentes lingüísticas

Fundéu. https://www.fundeu.es

Galimberti Jarman, B. y Russell, R. (eds.). (2008). Gran Diccionario Oxford / The Oxford Spanish Dictionary (3ª ed.). Oxford University Press.

Merriam-Webster. (s. f.). Merriam-Webster Unabridged. https://unabridged.merriam-webster.com/

Real Academia Española. (2019). Diccionario de la lengua española (DLE). https://dle.rae.es/

2. Diarios

Clarín (https://www.clarin.com/)

El País (https://elpais.com/)

La Nación (http://www.lanacion.com.ar)

Northern Times (https://www.northern-times.co.uk/)

II. REFERENCIAS

21.2A: Steps of Virus Infections—Biology LibreTexts. (s. f.). En Boundless General Biology. LibreTexts. Recuperado el 26 de octubre de 2020 en https://bio.libretexts.org/Bookshelves/Introductory_and_General_Biology/Book%3A_General_Biology_(Boundless)/21%3A_Viruses/21.2%3A_Virus_Infections_and_Hosts/21.2A%3A_Steps_of_Virus_Infections

3M. (s. f.). Reusable Respirators. Recuperado el 13 de abril de 2020 en https://www.3m.com/3M/en_US/company-us/all-3m-products/~/All-3M-Products/Safety/Personal-Safety/Personal-Protective-Equipment/Reusable-Respirators/?N=5002385+8709322+8711017+8711405+8720539+8720550+3294857497&rt=r3

Abbott RealTime SARS-CoV-2 Assay. (s. f.). Abbott. Recuperado el 7 de junio de 2020 en https://www.molecular.abbott/us/en/products/infectious-disease/RealTime-SARS-CoV-2-Assay

Abraham, S., Kienzle, T. E., Lapps, W. y Brian, D. A. (1990). Deduced sequence of the bovine coronavirus spike protein and identification of the internal proteolytic cleavage site. Virology, 176(1), 296-301. https://doi.org/10.1016/0042-6822(90)90257-R

Ackermann, H.-W., Berthiaume, L. y Tremblay, M. (1998). Virus Life in Diagrams. CRC Press.

Adam, D. C. y Cowling, B. J. (2 de junio de 2020). Opinion | Just Stop the Superspreading. The New York Times.

Agence France-Presse. (28 de marzo de 2020). Italy’s COVID-19 death toll tops 10,000 despite long coronavirus lockdown. Recuperado el 16 de mayo de 2020 en https://www.rawstory.com/2020/03/italys-covid-19-death-toll-tops-10000-despite-long-coronavirus-lockdown/

Agencia Española de Medicamentos y Productos Sanitarios y Agencia Estatal Boletín Oficial del Estado (eds.). (2015). Real Farmacopea Española, 5ª ed. Agencia Estatal Boletín Oficial del Estado. https://extranet.boe.es/index.php?referer=/farmacopea/index.php

Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., Ray, A. S., Cihlar, T., Siegel, D., Mackman, R. L., Clarke, M. O., Baric, R. S. y Denison, M. R. (2018). Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease. MBio, 9(2). https://doi.org/10.1128/mBio.00221-18

Ahammad, I. y Lira, S. S. (2020). Designing a novel mRNA vaccine against SARS-CoV-2: An immunoinformatics approach. International Journal of Biological Macromolecules, 162, 820-837. https://doi.org/10.1016/j.ijbiomac.2020.06.213

Ahmad, S., Navid, A., Farid, R., Abbas, G., Ahmad, F., Zaman, N., Parvaiz, N. y Azam, S. S. (2020). Design of a Novel Multi Epitope-Based Vaccine for Pandemic Coronavirus Disease (COVID-19) by Vaccinomics and Probable Prevention Strategy against Avenging Zoonotics. European Journal of Pharmaceutical Sciences, 151, 105387. https://doi.org/10.1016/j.ejps.2020.105387

Ahn, D.-G., Shin, H.-J., Kim, M.-H., Lee, S., Kim, H.-S., Myoung, J., Kim, B.-T. y Kim, S.-J. (2020). Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). Journal of Microbiology and Biotechnology, 30(3), 313-324. https://doi.org/10.4014/jmb.2003.03011

Al Badri, F. (2017). Surgical mask contact dermatitis and epidemiology of contact dermatitis in healthcare workers. Current Allergy and Clinical Immunology, 30(3), 183-188. https://www.researchgate.net/publication/323278369_Surgical_mask_contact_dermatitis_and_epidemiology_of_contact_dermatitis_in_healthcare_workers

Al Jazeera. (23 de marzo de 2020). Self-isolate or quarantine? Coronavirus terminology explained. https://www.aljazeera.com/news/2020/03/coronavirus-terminology-explained-covid-19-glossary-200323064432820.html

Alexandre, J., Cracowski, J.-L., Richard, V. y Bouhanick, B. (2020). Renin-angiotensin-aldosterone system and COVID-19 infection. Annales d’Endocrinologie, 81(2-3), 63-67. https://doi.org/10.1016/j.ando.2020.04.005

Altaf, R. (7 de abril de 2020). Fighting the invisible: How science of genomics is helping us know novel coronavirus? NORTHEAST NOW. https://nenow.in/opinion/fighting-the-invisible-how-science-of-genomics-is-helping-us-know-novel-coronavirus.html

Al-Tawfiq, J. A. y Rodriguez-Morales, A. J. (2020). Super-spreading events and contribution to transmission of MERS, SARS, and SARS-CoV-2 (COVID-19). Journal of Hospital Infection, 105(2), 111-112. https://doi.org/10.1016/j.jhin.2020.04.002

Altena, E., Baglioni, C., Espie, C. A., Ellis, J., Gavriloff, D., Holzinger, B., Schlarb, A., Frase, L., Jernelöv, S. y Riemann, D. (s. f.). Dealing with sleep problems during home confinement due to the COVID-19 outbreak: Practical recommendations from a task force of the European CBT-I Academy. Journal of Sleep Research, e13052. Publicación anticipada en línea. https://doi.org/10.1111/jsr.13052

Álvarez, E., Donado-Campos, J. y Morilla, F. (2015). New coronavirus outbreak. Lessons learned from the severe acute respiratory syndrome epidemic. Epidemiology & Infection, 143(13), 2882-2893. https://doi.org/10.1017/S095026881400377X

Alvarez, F., Argente, D. y Lippi, F. (2020). A Simple Planning Problem forCOVID-19 Lockdown. (EIEF Working Papers Series, n.^o 2005). Einaudi Institute for Economics and Finance (EIEF). https://ideas.repec.org/p/eie/wpaper/2005.html

Álvez González, F. (25-28 de septiembre de 2003). Infectología pediátrica Técnicas de diagnóstico rápido en infectología pediátrica. Su utilidad para el pediatra. En Sociedad Española de Pediatría Extrahospitalaria y Atención Primaria, Contenido científico del XVII Congreso 2003 Santander (pp. 59-66). https://www.sepeap.org/wp-content/uploads/2014/02/Contenido-Cient%C3%ADfico-del-XVII-Congreso-2003-Santander.pdf

Alzoughool, F. y Alanagreh, L. (2020). Coronavirus drugs: Using plasma from recovered patients as a treatment for COVID-19. The International Journal of Risk & Safety in Medicine. https://doi.org/10.3233/JRS-201017

Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C. y Garry, R. F. (2020). The proximal origin of SARS-CoV-2. Nature Medicine, 26(4), 450-452. https://doi.org/10.1038/s41591-020-0820-9

Angeletti, S., Benvenuto, D., Bianchi, M., Giovanetti, M., Pascarella, S. y Ciccozzi, M. (2020). COVID‐2019: The role of the nsp2 and nsp3 in its pathogenesis. Journal of Medical Virology, 92(6), 584-588. https://doi.org/10.1002/jmv.25719

Arden, K., Fatoye, F. y Yeowell, G. (2017). Evaluation of a rolling rehabilitation programme for patients with non‐specific low back pain in primary care: An observational cohort study. Journal of Evaluation in Clinical Practice, 23(2), 272-278. https://doi.org/10.1111/jep.12595

Arias, R. (13 de marzo de 2020). Actualización de la situación del coronavirus y cómo afecta al transporte. https://www.transporteprofesional.es/noticias-actualidad-transporte-logistica/transporte-de-mercancias/actualizacion-de-la-situacion-del-coronavirus-y-como-afecta-al-transporte

Artigas, M. y Flores, J. (2 de abril de 2020). Glosario del coronavirus: todos los términos que rodean al Covid-19. National Geographic España. https://www.nationalgeographic.com.es/ciencia/glosario-coronavirus-todos-terminos-que-rodean-covid-19_15314

Ashfor, J. (25 de marzo de 2020). Coronavirus glossary: from shielding, self-isolating and social distancing to covidiots. The Week. https://www.theweek.co.uk/coronavirus/106204/coronavirus-glossary-from-shielding-self-isolating-and-social-distancing-to

Aslam, S. y Mehra, M. R. (2020). COVID-19: Yet another coronavirus challenge in transplantation. The Journal of Heart and Lung Transplantation, 39(5), 408-409. https://doi.org/10.1016/j.healun.2020.03.007

Asociación Española de Normalización y Certificación [AENOR]. (Diciembre de 2019). Mascarillas quirúrgicas. Requisitos y métodos de ensayo (UNE-EN 14683:2019+AC:2019).

Asociación Española de Normalización y Certificación [AENOR]. (Enero de 2010). Dispositivos de protección respiratoria. Medias máscaras filtrantes de protección contra partículas. Requisitos, ensayos, marcado (UNE-EN 149:2001+A1:2010).

Astuti, I. y Ysrafil. (2020). Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): An overview of viral structure and host response. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14(4), 407-412. https://doi.org/10.1016/j.dsx.2020.04.020

Atkinson, J., Chartier, Y., Pessoa-Silva, C. L., Jensen, P., Li, Y. y Seto, W. H. (eds.). (2010). Ventilación natural para el control de las infecciones en entornos de atención de la salud. Organización Panamericana de la Salud. https://www.who.int/water_sanitation_health/publications/natural_ventilation/es/

Atkinson, J., Chartier, Y., Pessoa-Silva, C. L., Jensen, P., Li, Y. y Seto, W. H. (2009). Natural ventilation for infection control in health-care settings. Organización Mundial de la Salud. https://apps.who.int/iris/bitstream/handle/10665/44167/9789241547857_eng.pdf

Atluri, S., Manchikanti, L. y Hirsch, J. A. (2020). Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use. Pain Physician, 23(2), E71-E83. https://www.painphysicianjournal.com/current/pdf?article=NzAyNA%3D%3D&journal=125

Atri, D., Siddiqi, H. K., Lang, J., Nauffal, V., Morrow, D. A. y Bohula, E. A. (2020). COVID-19 for the Cardiologist: A Current Review of the Virology, Clinical Epidemiology, Cardiac and Other Clinical Manifestations and Potential Therapeutic Strategies. JACC: Basic to Translational Science. https://doi.org/10.1016/j.jacbts.2020.04.002

Austrian, K., Pinchoff, J., Tidwell, J. B., White, C., Abuya, T., Kangwana, B., Ochako, R., Wanyungu, J., Muluve, E., Mbushi, F., Mwanga, D., Nzioki, M. y Ngo, T. D. (6 de abril de 2020). COVID-19 Related Knowledge, Attitudes, Practices and Needs of Households in Informal Settlements in Nairobi, Kenya. Bulletin of the World Health Organization. Publicación anticipada en línea. http://dx.doi.org/10.2471/BLT.20.260281

Ávila de Tomás, J. F. (2020). CORONAVIRUS COVID-19; patogenia, prevención y tratamiento (2.^a ed). SALUSPLAY editorial. https://ebevidencia.com/wp-content/uploads/2020/03/CORONAVIRUS-COVID-19_-patogenia-prevenci%C3%B3n-y-tratamiento-2%C2%AA-Ed-15.03.2020-ISBN-978-84-16861-95-8-.pdf

Bacha, U., Barrila, J., Gabelli, S. B., Kiso, Y., Amzel, L. M. y Freire, E. (2008). Development of Broad-Spectrum Halomethyl Ketone Inhibitors Against Coronavirus Main Protease 3CLpro. Chemical Biology & Drug Design, 72(1), 34-49. https://doi.org/10.1111/j.1747-0285.2008.00679.x

Badri, F. M. A. (2017). Surgical mask contact dermatitis and epidemiology of contact dermatitis in healthcare workers: Allergies in the workplace. Current Allergy & Clinical Immunology, 30(3), 183-188. https://journals.co.za/content/journal/10520/EJC-c3ca4ee66

Baeva, M. (24 de abril de 2020). Call for EU to do more to protect unaccompanied refugee children from Coronavirus. The Parliament Magazine. https://www.theparliamentmagazine.eu/news/article/call-for-eu-to-do-more-to-protect-unaccompanied-refugee-children-from-coronavirus

Bahadır, E. B. y Sezgintürk, M. K. (2016). Lateral flow assays: Principles, designs and labels. TrAC Trends in Analytical Chemistry, 82, 286-306. https://doi.org/10.1016/j.trac.2016.06.006

Ballesteros Sanz, M. Á., Hernández-Tejedor, A., Estella, Á., Jiménez Rivera, J. J., González de Molina Ortiz, F. J., Sandiumenge Camps, A., Vidal Cortés, P., de Haro, C., Aguilar Alonso, E., Bordejé Laguna, L., García Sáez, I., Bodí, M., García Sánchez, M., Párraga Ramírez, M. J., Alcaraz Peñarrocha, R. M., Amézaga Menéndez, R., Burgueño Laguía, P., Rubio Sanchiz, O., Rodríguez Yago, M. Á., … Martín Delgado, M. C. (2020). Recomendaciones de «hacer» y «no hacer» en el tratamiento de los pacientes críticos ante la pandemia por coronavirus causante de COVID-19 de los Grupos de Trabajo de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias (SEMICYUC). Medicina Intensiva, 44(6), 371-388. https://doi.org/10.1016/j.medin.2020.04.001

Ballout, R. A., Sviridov, D., Bukrinsky, M. I. y Remaley, A. T. (2020). The lysosome: A potential juncture between SARS‐CoV‐2 infectivity and Niemann‐Pick disease type C, with therapeutic implications. The FASEB Journal, 34(6), 7253-7264. https://doi.org/10.1096/fj.202000654R

Bamforth, E. (28 de enero de 2020). Should I be freaking out? What can you do to protect yourself from the China coronavirus. https://www.cleveland.com/news/2020/01/should-i-be-freaking-out-what-can-you-do-to-protect-yourself-from-the-china-coronavirus.html

Banerjee, S., Guedj, J., Ribeiro, R. M., Moses, M. y Perelson, A. S. (2016). Estimating biologically relevant parameters under uncertainty for experimental within-host murine West Nile virus infection. Journal of The Royal Society Interface, 13(117), 20160130. https://doi.org/10.1098/rsif.2016.0130

Bar-On, Y. M., Flamholz, A., Phillips, R. y Milo, R. (2020). SARS-CoV-2 (COVID-19) by the numbers. eLife, 9, e57309. https://doi.org/10.7554/eLife.57309

Barros de Souza, D., Da Cunha, J. T. S., Figueiroa, E., Correia, J. B., Da Silva, H. P., De Lima Filho, J. L., Albuquerque, J. y Santos, F. A. N. (2020). Using discrete Ricci curvatures to infer COVID-19 epidemic network fragility and systemic risk. medRxiv. https://doi.org/10.1101/2020.04.01.20047225

Becker, A. (25 de marzo de 2020). COVID-19 crisis catalog: A glossary of terms. Texas Medical Center. https://www.tmc.edu/news/2020/03/covid-19-crisis-catalog-a-glossary-of-terms/

Beigel, J. H., Nam, H. H., Adams, P. L., Krafft, A., Ince, W. L., El-Kamary, S. S. y Sims, A. C. (2019). Advances in respiratory virus therapeutics – A meeting report from the 6th isirv Antiviral Group conference. Antiviral Research, 167, 45-67. https://doi.org/10.1016/j.antiviral.2019.04.006

Belouzard, S., Millet, J. K., Licitra, B. N. y Whittaker, G. R. (2012). Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses, 4(6), 1011–1033. https://doi.org/10.3390/v4061011

Beltrán Pavez, C. A. (2018). Desarrollo de inmunógenos y estrategias de vacunación para optimizar la inducción de anticuerpos neutralizantes de amplio espectro frente al VIH-1 [Tesis doctoral, Universitat de Barcelona]. https://dialnet.unirioja.es/servlet/tesis?codigo=251793

Bergmann, C. C. y Silverman, R. H. (2020). COVID-19: Coronavirus replication, pathogenesis, and therapeutic strategies. Cleveland Clinic Journal of Medicine, 87(6), 321-327. https://doi.org/10.3949/ccjm.87a.20047

Bernacchi, A. S. y Valles, E. G. (2011). Desafíos para los laboratorios biomédicos en materia de biocustodia. International Journal of Biosafety and Security, 1(2). http://www.seer.ufu.br/index.php/intbiosafetybiosecurity/article/view/9155

Berríos, D. C. F., Olivares, D. C. F. y Carvajal, D. L. A. (2020). Prevención y medidas de protección frente a la infección por SARS-CoV-2. Neumología Pediátrica, 15(2), 308-316. https://www.neumologia-pediatrica.cl/wp-content/uploads/2020/05/2020-15-2-4-es.pdf

Bhandari, R., Sun, F. y Pan, Q. (2020). An overview of SARS-CoV-2: Virology, epidemiology, pathogenesis and treatment. Novel Research in Microbiology Journal, 4(3), 746-765. https://doi.org/10.21608/nrmj.2020.95319

Biassoni, R. y Raso, A. (eds.). (2014). Quantitative Real-Time PCR: Methods and Protocols. Springer New York. https://doi.org/10.1007/978-1-4939-0733-5

Bilal, M., Nazir, M. S., Parra-Saldivar, R. y Iqbal, H. M. N. (2020). 2019-NCOV/COVID-19 – Approaches to viral vaccine development and preventive measures. Journal of Pure and Applied Microbiology, 14(1). https://doi.org/10.22207/JPAM.14.1.05

Biosafety level. (7 de abril de 2020). En Wikipedia. https://en.wikipedia.org/w/index.php?title=Biosafety_level&oldid=949586350

BioSolveIT. (s. f.). SeeSAR. (s. f.). Recuperado el 3 de mayo de 2020 en https://www.biosolveit.de/SeeSAR/

BioVision. (5 de mayo de 2020). Recombinant proteins for COVID-19 research. News Medical. https://www.news-medical.net/news/20200505/Recombinant-proteins-for-COVID-19-research.aspx

Birbuet, J. C. y López, R. (15 de abril de 2020). Dinámica de expansión del COVID-19 en Bolivia durante las primeras seis semanas. Guardiana. https://guardiana.com.bo/especiales/dinamica-de-expansion-del-covid-19-en-bolivia-durante-las-primeras-6-semanas/

Biswas, J. (22 de octubre de 2020). New COVID-19 Fact: SARS-CoV-2 Virus Uses A Second «Key» To Invade Human Cells, Finds Study. International Business Times. https://www.ibtimes.sg/new-covid-19-fact-sars-cov-2-virus-uses-second-key-invade-human-cells-finds-study-52740

Biswas, J. (22 de octubre de 2020). New COVID-19 Fact: SARS-CoV-2 Virus Uses A Second «Key» To Invade Human Cells, Finds Study. International Business Times. https://www.ibtimes.sg/new-covid-19-fact-sars-cov-2-virus-uses-second-key-invade-human-cells-finds-study-52740

Bohannon, R. W. y Crouch, R. (2019). 1-Minute Sit-to-Stand Test: Systematic review of procedures, performance, and clinimetric properties. Journal of Cardiopulmonary Rehabilitation and Prevention, 39(1), 2-8. https://doi.org/10.1097/HCR.0000000000000336

Bolles, M., Donaldson, E. y Baric, R. (2011). SARS-CoV and emergent coronaviruses: Viral determinants of interspecies transmission. Current Opinion in Virology, 1(6), 624-634. https://doi.org/10.1016/j.coviro.2011.10.012

Botero-Rodríguez, F., Franco, Ó. H., Gómez-Restrepo, C. (2020). Glosario para una pandemia: el ABC de los conceptos sobre el coronavirus. Biomédica, 40(Supl. 2), 16-26. https://doi.org/10.7705/biomedica.5605

Boucher, A. (20 de enero de 2020). China Confirms Human-to-Human Transmission of Coronavirus. People. https://people.com/health/china-confirms-human-to-human-transmission-coronavirus-as-british-tourist-hospitalized-thailand/

Bouvet, M., Lugari, A., Posthuma, C. C., Zevenhoven, J. C., Bernard, S., Betzi, S., Imbert, I., Canard, B., Guillemot, J.-C., Lécine, P., Pfefferle, S., Drosten, C., Snijder, E. J., Decroly, E. y Morelli, X. (2014). Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes. The Journal of Biological Chemistry, 289(37), 25783-25796. http://www.jbc.org/lookup/doi/10.1074/jbc.M114.577353

Braun, E. y Sauter, D. (2019). Furin-mediated protein processing in infectious diseases and cancer. Clinical & Translational Immunology, 8(8), e1073. https://doi.org/10.1002/cti2.1073

Brenner, S. R. (2020). Covid-19, TMPRSS2, and whether android regulation affects pandemic virus gender incidence and age distribution of disease. Medical Hypotheses, 140, 109773. https://doi.org/10.1016/j.mehy.2020.109773

British Standards Institution [BSI]. (31 de marzo de 2019, corregida en agosto de 2019). Medical face masks – Requirements and test methods. (BS EN 14683:2019).

Britt, D. (10 de julio de 2017). CE Article: BiPAP Essentials for Prehospital Providers. EMS World. https://www.emsworld.com/218042/ce-article-bipap-essentials-prehospital-providers

Brown, N. (2019). Communicable Diseases and the Workplace. Cornell University, Workplace Health and Safety Program. https://digitalcommons.ilr.cornell.edu/manuals/18

Burton, D. R. y Walker, L. M. (2020). Rational Vaccine Design in the Time of COVID-19. Cell Host & Microbe, 27(5), 695-698. https://doi.org/10.1016/j.chom.2020.04.022

Bustin, S. A. y Nolan, T. (2020). RT-qPCR Testing of SARS-CoV-2: A Primer. International Journal of Molecular Sciences, 21(8), 3004. https://doi.org/10.3390/ijms21083004

Bzówka, M., Mitusińska, K., Raczyńska, A., Samol, A., Tuszyński, J. A. y Góra, A. (2020). Structural and Evolutionary Analysis Indicate That the SARS-CoV-2 Mpro Is a Challenging Target for Small-Molecule Inhibitor Design. International Journal of Molecular Sciences, 21(9), 3099. https://doi.org/10.3390/ijms21093099

Caddy, S. (2020). Developing a vaccine for covid-19. BMJ, 369, m1790. https://doi.org/10.1136/bmj.m1790

Cait, K. (3 de mayo de 2020). Coronavirus symptoms: From «COVID toe» to headaches. The New Daily. https://thenewdaily.com.au/news/2020/05/03/coronavirus-symptoms-list-toes/

Caldaria, A., Conforti, C., Di Meo, N., Dianzani, C., Jafferany, M., Lotti, T., Zalaudek, I. y Giuffrida, R. (2020). COVID ‐19 and SARS: Differences and similarities [Carta al director]. Dermatologic Therapy, 33(4), e13395. https://doi.org/10.1111/dth.13395

Callaway, E. (2020). The race for coronavirus vaccines: a graphical guide. Nature, 580(7805), 576-577. https://doi.org/10.1038/d41586-020-01221-y

Cao, Y., Li, Q., Chen, J., Guo, X., Miao, C., Yang, H., Chen, Z., Li, C. y Li, L. (2020). Hospital Emergency Management Plan During the COVID-19 Epidemic. Academic Emergency Medicine, 27(4), 309-311. https://doi.org/10.1111/acem.13951

Capiscol Pérez de Tudela, M. (2007). Requerimientos de secuencia para la replicación y la encapsidación de minigenomas derivados del coronavirus de la gastroenteritis porcina transmisible [Tesis doctoral, Universidad Autónoma de Madrid]. https://repositorio.uam.es/handle/10486/2107

Carranco Dueñas, J. A. (2015). Excreción viral prolongada en un paciente pediátrico inmunocomprometido con influenza A H1N1 (2009): Reporte de un caso y revisión de la literatura. Alergia, Asma e Inmunología Pediátricas, 24(3), 91-94. https://pdfs.semanticscholar.org/55d4/3f4b40b24060f8409cfa2bea8228a370ec7c.pdf

Carter, L. J., Garner, L. V., Smoot, J. W., Li, Y., Zhou, Q., Saveson, C. J., Sasso, J. M., Gregg, A. C., Soares, D. J., Beskid, T. R., Jervey, S. R. y Liu, C. (2020). Assay Techniques and Test Development for COVID-19 Diagnosis. ACS Central Science, 6(5), 591-605. https://doi.org/10.1021/acscentsci.0c00501

Castillo Martín, C. (2016). Infecciones emergentes causadas por coronavirus. Los virus SARS-CoV y MERS-CoV [Trabajo de fin de grado, Universidad de Sevilla]. https://idus.us.es/handle/11441/65125

Centers for Disease Control and Prevention. (s. f.). Guidance for the Selection and Use of Personal Protective Equipment (PPE) in Healthcare Settings. https://www.cdc.gov/hai/pdfs/ppe/ppeslides6-29-04.pdf

Centers for Disease Control and Prevention. (8 de enero de 2004). Severe Acute Respiratory Syndrome (SARS). Appendix 2. Glossary. Core Document. Public Health Guidance for Community-Level Preparedness and Response to Severe Acute Respiratory Syndrome (SARS) Version 2/3. https://www.cdc.gov/sars/guidance/core/app2.pdf

Centers for Disease Control and Prevention. (13 de enero de 2004). Información básica sobre el SRAS. https://www.cdc.gov/sars/about/fs-SARS-sp.pdf

Centers for Disease Control and Prevention. (2020). Interim U.S. Guidance for Risk Assessment and Public Health Management of Healthcare Personnel with Potential Exposure in a Healthcare Setting to Patients with Coronavirus Disease 2019 (COVID-19). Recuperado el 11 de febrero de 2020 en https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-risk-assesment-hcp.html

Centers for Disease Control and Prevention. (21 de marzo de 2020). Interim Guidance for Businesses and Employers to Plan and Respond to Coronavirus Disease 2019 (COVID-19). https://www.cdc.gov/coronavirus/2019-ncov/community/guidance-business-response.html

Centers for Disease Control and Prevention. (20 de mayo de 2020). COVID-19 Pandemic Planning Scenarios. https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios-archive/planning-scenarios-2020-05-20.pdf

Centers for Disease Control and Prevention. (4 de septiembre de 2020). COVIDView, Key Updates for Week 35. https://www.cdc.gov/coronavirus/2019-ncov/covid-data/covidview/past-reports/09042020.html

Centers for Disease Control and Prevention y National Institute for Occupational Safety and Health. (septiembre de 2019). Types of respiratory protection. https://www.cdc.gov/niosh/npptl/images/infographics/TypesRespProtectLG.jpg

Cerezo Lira, G., Zárate Conde, K., Alpuche-Lazcano, S., Cabello, C., Tato, P. y Tirado, R. (2016). Diagnóstico molecular para la detección de metapneumovirus humano a partir de aislados virales en pacientes pediátricos con infección respiratoria aguda. Investigación en discapacidad, 5(2), 88-95. https://www.medigraphic.com/pdfs/invdis/ir-2016/ir162c.pdf

Cerón-Serrano, A., Jiménez-Castellano, R. y Gómez-Campos, A. M. (2017). Prevención y cuidados de enfermería en el primer caso de enfermedad del virus Ébola adquirida fuera de África. Enfermería Clínica, 27(2), 125-131. https://doi.org/10.1016/j.enfcli.2016.11.003

Chang, C. K., Chen, C. M., Chiang, M. H., Hsu, Y. L. y Huang, T. H. (2013). Transient oligomerization of the SARS-CoV N protein–implication for virus ribonucleoprotein packaging. PloS one, 8(5), e65045. https://doi.org/10.1371/journal.pone.0065045

Chang, Y.-S., Ko, B.-H., Ju, J.-C., Chang, H.-H., Huang, S.-H. y Lin, C.-W. (2020). SARS Unique Domain (SUD) of Severe Acute Respiratory Syndrome Coronavirus Induces NLRP3 Inflammasome-Dependent CXCL10-Mediated Pulmonary Inflammation. International Journal of Molecular Sciences, 21(9). https://doi.org/10.3390/ijms21093179

Chebib, H. E., McArthur, K., Gorbonosov, M. y Domachowske, J. B. (2020). Anaerobic Necrotizing Pneumonia: Another Potential Life-threatening Complication of Vaping? Pediatrics, 145(4). https://doi.org/10.1542/peds.2019-3204

Chen, C., Li, X., Li, G., Zhao, L., Duan, S., Yan, T., Feng, Z. y Ma, X. (2018). Use of a rapid reverse-transcription recombinase aided amplification assay for respiratory syncytial virus detection. Diagnostic Microbiology and Infectious Disease, 90(2), 90-95. https://doi.org/10.1016/j.diagmicrobio.2017.10.005

Chen, J. H.-K., Yip, C. C.-Y., Poon, R. W.-S., Chan, K.-H., Cheng, V. C.-C., Hung, I. F.-N., Chan, J. F.-W., Yuen, K.-Y. y To, K. K.-W. (2020). Evaluating the use of posterior oropharyngeal saliva in a point-of-care assay for the detection of SARS-CoV-2. Emerging Microbes & Infections, 0(ja), 1-14. https://doi.org/10.1080/22221751.2020.1775133

Chen, J.-W. y Chen, J.-M. (2020). Potential of live pathogen vaccines for defeating the COVID-19 pandemic: History and mechanism. Journal of Medical Virology, 92(9), 1469-1474. https://doi.org/10.1002/jmv.25920

Chen, L. y Zhong, L. (2020). Genomics functional analysis and drug screening of SARS-CoV-2. Genes & Diseases. https://doi.org/10.1016/j.gendis.2020.04.002

Chen, Q., Allot, A. y Lu, Z. (2020). Keep up with the latest coronavirus research. Nature, 579(7798), 193. https://doi.org/10.1038/d41586-020-00694-1

Chen, W.-H., Tao, X., Agrawal, A. S., Algaissi, A., Peng, B.-H., Pollet, J., Strych, U., Bottazzi, M. E., Hotez, P. J., Lustigman, S., Du, L., Jiang, S. y Tseng, C.-T. K. (2020). Yeast-expressed SARS-CoV recombinant receptor-binding domain (RBD219-N1) formulated with aluminum hydroxide induces protective immunity and reduces immune enhancement. Vaccine, 38(47), 7533-7541. https://doi.org/10.1016/j.vaccine.2020.09.061

Cherney, K. y Rogers, G. (s. f.). Cross Infection | Definition and Patient Education. Healthline. Recuperado el 18 de mayo de 2020 en https://www.healthline.com/health/cross-infection

Chire Saire, J. E. y Lemus-Martin, R. (2020). Infoveillance to Analyze Covid19 Impact on Central America Population. medRxiv. https://doi.org/10.1101/2020.05.26.20113514

Ciotti, C., Pellissier, G., Rabaud, C., Lucet, J.-C., Abiteboul, D. y Bouvet, E. (2012). Effectiveness of respirator masks for healthcare workers, in France. Médecine et Maladies Infectieuses, 42(6), 264-269. https://doi.org/10.1016/j.medmal.2012.05.001

City of Downey. (s. f.) Emergency Preparedness. Recuperado el 4 de octubre de 2020 en https://www.downeyca.org/our-city/departments/emergency-preparedness

Claros, G. (10 de marzo de 2020). COVID-19 es femenino, queridos míos. El nanoblog de Gonz. http://mgclaros.blogspot.com/2020/03/covid-19-es-femenino-queridos-mios.html

Claros, G. y Saladrigas, M. V. (2004). Vocabulario inglés-español de bioquímica y biología molecular (5.^a entrega). Panace@ 5(16), 109-126. https://www.tremedica.org/wp-content/uploads/n16_tradyterm_Claros-Saladrigas-GonzalezH.pdf

Claros, G. y Saladrigas, V. (2003). Vocabulario inglés-español de bioquímica y biología molecular (2.^a entrega). Panace@ 4(11), 18-29. https://www.tremedica.org/wp-content/uploads/n11-tradytermbiomolecular.pdf

Claros, G., Saladrigas, V. y González-Halphen, D. (2003). Vocabulario inglés- español de bioquímica y biología molecular (3.^a entrega). Panace@, 4(12), 136-142. https://www.tremedica.org/wp-content/uploads/n12_tradyterm_Claros-Saladriga-Halphen.pdf

Clemson University. (s. f.). COVID-19 Glossary of Terms. Recuperado el 13 de abril de 2020 en https://www.clemson.edu/coronavirus/glossary.html

Clínica Universidad de Navarra. (s. f.). Diccionario médico. https://www.cun.es/diccionario-medico/terminos/virus-rna

Collins, A., Speer, B., Waggoner, B., Rob, Whitney, C. y Rieboldt, S. (s. f.). UCMP Glossary. Recuperado el 13 de abril de 2020 en https://ucmp.berkeley.edu/glossary/glossary.html

Collins, F. (3 de septiembre de 2020). Citizen Scientists Take on the Challenge of Long-Haul COVID-19. NIH Director’s Blog. https://directorsblog.nih.gov/2020/09/03/citizen-scientists-take-on-the-challenge-of-long-haul-covid-19/

Comité Europeo de Normalización. (Septiembre de 1998). Respiratory protective devices – Half masks and quarter masks – Requirements, testing, marking. (EN 140:1998 E).

Compartmental models in epidemiology. (21 de abril de 2020). En Wikipedia. https://en.wikipedia.org/wiki/Compartmental_models_in_epidemiology

Cong, Y., Verlhac, P. y Reggiori, F. (2017). The Interaction between Nidovirales and Autophagy Components. Viruses, 9(7), 182. https://doi.org/10.3390/v9070182

Consejo General de Colegios Farmacéuticos. (16 de abril de 2020). El COVID-19 y el uso de mascarillas. https://www.portalfarma.com/Profesionales/campanaspf/Asesoramiento-salud-publica/infeccion-coronavirus-2019-nCoV/Documents/mascarillas-coronavirus.pdf

Consolo, U., Bellini, P., Bencivenni, D., Iani, C. y Checchi, V. (2020). Epidemiological Aspects and Psychological Reactions to COVID-19 of Dental Practitioners in the Northern Italy Districts of Modena and Reggio Emilia. International Journal of Environmental Research and Public Health, 17(10), 3459. https://doi.org/10.3390/ijerph17103459

Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., Mulders, D. G., Haagmans, B. L., Van der Veer, B., Van den Brink, S., Wijsman, L., Goderski, G., Romette, J., Ellis, J., Zambon, M., … Drosten, C. (2020). Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance, 25(3), 1-8. https://doi.org/10.2807/1560-7917.ES.2020.25.3.2000045

Coronavirus disease 2019. (s. f.). En Wikiwand. Recuperado el 13 de abril de 2020 en https://www.wikiwand.com/en/Coronavirus_disease_2019

Coronavirus hijacks your body cells and lives off them. (24 de marzo de 2020). Daily Nation. https://nation.africa/kenya/news/coronavirus-hijacks-your-body-cells-and-lives-off-them-280442

Coronavirus. 20A.EU1: advierten que una nueva variante del coronavirus se expande por Europa. (30 de octubre de 2020). La Nación. https://www.lanacion.com.ar/el-mundo/coronavirus-nueva-cepa-se-estaria-expandiendo-europa-nid2493875

Coroners Court of Victoria. (s. f.). Coronavirus update. Recuperado el 21 de octubre de 2020 en https://www.coronerscourt.vic.gov.au/coronavirus-update

Corr, J. (5 de marzo de 2020). Coronavirus in Ireland. Professor warns of importance to come forward with Covid-19 symptoms to avoid large outbreak. The Irish Sun. https://www.thesun.ie/news/5169009/coronavirus-in-ireland-queens-symptoms-come-forward/

Cottam, E. M., Whelband, M. C. y Wileman, T. (2014). Coronavirus NSP6 restricts autophagosome expansion. Autophagy, 10(8), 1426-1441. https://doi.org/10.4161/auto.29309

Coutard, B., Valle, C., de Lamballerie, X., Canard, B., Seidah, N. G. y Decroly, E. (2020). The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Research, 176, 104742. https://doi.org/10.1016/j.antiviral.2020.104742

COVID-19 Antigen Rapid Test Kit. (s. f.). JOYSBIO Biotechnology. Recuperado el 26 de octubre de 2020 en https://en.joysbio.com/covid-19-antigen-rapid-test-kit/

Cuan-Baltazar, J. Y., Muñoz-Perez, M. J., Robledo-Vega, C., Pérez-Zepeda, M. F. y Soto-Vega, E. (2020). Misinformation of COVID-19 on the Internet: Infodemiology Study. JMIR Public Health and Surveillance, 6(2), e18444. https://doi.org/10.2196/18444

Cunningham, A. C., Goh, H. P. y Koh, D. (2020). Treatment of COVID-19: Old tricks for new challenges. Critical Care, 24(1), 91. https://doi.org/10.1186/s13054-020-2818-6

Cyranoski, D. (2020). Profile of a killer: the complex biology powering the coronavirus pandemic. Nature, 581(7806), 22-26. https://doi.org/10.1038/d41586-020-01315-7

D’Adamo, H., Yoshikawa, T. y Ouslander, J. G. (2020). Coronavirus Disease 2019 in Geriatrics and Long-Term Care: The ABCDs of COVID-19. Journal of the American Geriatrics Society, 68(5), 912-917. https://doi.org/10.1111/jgs.16445

Dabhi, B. (27 de octubre de 2020). Gujarat begins counting frontline Covid workers for on-priority vaccine. Ahmedabad Mirror. https://ahmedabadmirror.indiatimes.com/ahmedabad/cover-story/gujarat-begins-counting-frontline-covid-workers-for-on-priority-vaccine/articleshow/78798921.cms

Daly, J. L., Simonetti, B., Klein, K., Chen, K.-E., Williamson, M. K., Antón-Plágaro, C., Shoemark, D. K., Simón-Gracia, L., Bauer, M., Hollandi, R., Greber, U. F., Horvath, P., Sessions, R. B., Helenius, A., Hiscox, J. A., Teesalu, T., Matthews, D. A., Davidson, A. D., Collins, B. M., … Yamauchi, Y. (2020). Neuropilin-1 is a host factor for SARS-CoV-2 infection. Science. https://doi.org/10.1126/science.abd3072

Davies, D. (29 de abril de 2020). Compared With China, U.S. Stay-At-Home Has Been «Giant Garden Party,» Journalist Says. Wbur. https://www.wbur.org/npr/847755751/compared-to-china-u-s-stay-at-home-has-been-a-giant-garden-party-journalist-says

Davies, M. (2020-). Coronavirus Corpus. 670 million words. Disponible en línea en https://www.english-corpora.org/corona/.

Day, M. J. y Schultz, R. D. (2010). Veterinary Immunology: Principles and Practice. CRC Press.

Del Rio-Chanona, R. M., Mealy, P., Pichler, A., Lafond, F. y Farmer, D. (2020). Supply and demand shocks in the COVID-19 pandemic: An industry and occupation perspective. Oxford Review of Economic Policy, 36(Supplement_1), S94-S137. https://doi.org/10.1093/oxrep/graa033

Detels, R., Gulliford, M., Karim, Q. A. y Tan, C. C. (2015). Oxford Textbook of Global Public Health. Oxford University Press.

Deuskar, N. (22 de julio de 2020). Some drug makers say they plan to profit from coronavirus vaccine. MSN News. https://www.msn.com/en-in/news/other/some-drug-makers-say-they-plan-to-profit-from-coronavirus-vaccine/ar-BB172e81

De-Zolt, S., Altschmied, J., Ruiz, P., von Melchner, H. y Schnütgen, F. (2009). Gene-trap vectors and mutagenesis. En W. Wurst y R. Kühn (eds.), Gene Knockout Protocols (2ª ed., pp. 29-47). Humana Press. https://doi.org/10.1007/978-1-59745-471-1_3

Dilucca, M., Forcelloni, S., Georgakilas, A. G., Giansanti, A. y Pavlopoulou, A. (2020). Codon Usage and Phenotypic Divergences of SARS-CoV-2 Genes. Viruses, 12(5), 498. https://doi.org/10.3390/v12050498

Dolgin, E. (2020). Cancer-eating immune cells kitted out with CARs. Nature Biotechnology, 38(5), 509-511. https://doi.org/10.1038/s41587-020-0520-5

Domínguez Dueñas, L. y Amador-Bedolla, C. (2020). El origen de COVID-19: Lo que se sabe, lo que se supone y (muy poquito) sobre las teorías de complot. Educación Química, 31(2), 3-11. http://dx.doi.org/10.22201/fq.18708404e.2020.2.75461

Dreux, M. y Chisari, F. V. (2010). Viruses and the autophagy machinery. Cell Cycle, 9(7), 1295-1307. https://doi.org/10.4161/cc.9.7.11109

Du, L., Yang, Y., Zhou, Y., Lu, L., Li, F. y Jiang, S. (2017). MERS-CoV spike protein: a key target for antivirals. Expert opinion on therapeutic targets, 21(2), 131–143. https://doi.org/10.1080/14728222.2017.1271415

Duarte, M. (2004). Aislamientos. Revista del Hospital Materno Infantil Ramón Sardá, 24(4), 194-200. http://www.sarda.org.ar/images/Aislamientos.pdf

Ducharme, J. (30 de enero de 2020). The coronavirus outbreak is now a public health emergency of international concern. Here’s what that means. TIME. https://time.com/5774747/coronavirus-who-public-health-emergency/

Dyer, C. (2020). Covid-19: Coroners needn’t investigate PPE policy failures in deaths of NHS staff, new guidance says. BMJ, m1806. https://doi.org/10.1136/bmj.m1806

Ejaz, K., Kauser, T. y Siddiqa, A. (2020). Comprehensive overview of COVID-19 clinical trials. Journal of the Pakistan Medical Association, 0, 1. https://doi.org/10.5455/JPMA.37

Erasmus, J. H., Khandhar, A. P., O’Connor, M. A., Walls, A. C., Hemann, E. A., Murapa, P., Archer, J., Leventhal, S., Fuller, J. T., Lewis, T. B., Draves, K. E., Randall, S., Guerriero, K. A., Duthie, M. S., Carter, D., Reed, S. G., Hawman, D. W., Feldmann, H., Gale, M., … Fuller, D. H. (2020). An Alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates. Science Translational Medicine, 12(555), eabc9396. https://doi.org/10.1126/scitranslmed.abc9396

España. Ley 44/2003, de 21 de noviembre, de ordenación de las profesiones sanitarias. Boletín Oficial del Estado, 22 de noviembre de 2003, núm. 280, pp. 41442 a 41458. https://www.boe.es/buscar/act.php?id=BOE-A-2003-21340

Espinosa García, J. y Román Galán, T. (1998). La medida de las actitudes usando las técnicas de Likert y de diferencial semántico. Enseñanza de las ciencias: revista de investigación y experiencias didácticas, 16(3), 477-84. https://www.raco.cat/index.php/Ensenanza/article/view/21551/21385

Esposito, L. (2 de abril de 2020). Coronavirus Glossary: Defining the words used to describe a pandemic. U.S. News. https://health.usnews.com/conditions/articles/coronavirus-glossary

European Centre for Disease Prevention and Control. (s. f.) Coronavirus disease. https://www.ecdc.europa.eu/en

European Chemicals Agency (ECHA). (s. f.). Thymol. En InfoCards. Recuperado el 13 de abril de 2020 en https://echa.europa.eu/substance-information/-/substanceinfo/100.001.768

European Directorate for the Quality of Medicines (EDQM) (ed.). (2019). European Pharmacopoeia (Ph. Eur.) 10th Ed. https://www.edqm.eu/en/european_pharmacopoeia_10th_edition

European Molecular Biology Laboratory. (s. f.). SMART (versión 8.0) [Programa informático]. http://smart.embl-heidelberg.de/help/smart_about.shtml

Eysenbach, G. (2009). Infodemiology and Infoveillance: Framework for an Emerging Set of Public Health Informatics Methods to Analyze Search, Communication and Publication Behavior on the Internet. Journal of Medical Internet Research, 11(1). https://doi.org/10.2196/jmir.1157

Fallows, J. (15 de marzo de 2019). Three Implications of the Boeing 737 Max Crashes. The Atlantic. https://www.theatlantic.com

Featuresdesk. (17 de febrero de 2020). Quarantine Facility To Rise In Zamboanga City. PAGEONE. http://pageone.ph/quarantine-facility-to-rise-in-zamboanga-city/

Fehr, A. R. y Perlman, S. (2015). Coronaviruses: An Overview of Their Replication and Pathogenesis. En H. Maier, E. Bickerton y P. Britton (eds.), Coronaviruses: Methods and Protocols, vol. 1282. (pp. 1-23). Humana Press. https://doi.org/10.1007/978-1-4939-2438-7_1

Ferro, F., Elefante, E., Puxeddu, I., Baldini, C., Bartoloni, E., Baratè, C., Galimberti, S., Talarico, R., Mosca, M. y Bombardieri, S. (2020). COVID-19: The new challenge for rheumatologists. First update [Editorial]. Clinical and Experimental Rheumatology, 38, 373-382. https://www.clinexprheumatol.org/article.asp?a=15855

Fielding, J. (24 de febrero de 2020). Coronavirus and what needs to be done to get in front of global pandemics [Text]. TheHill. https://thehill.com/opinion/healthcare/484381-coronavirus-and-what-needs-to-be-done-to-get-in-front-of-global-pandemics

FIND. SARS-CoV-2 diagnostic pipeline. Recuperado el 16 de octubre en https://www.finddx.org/covid-19/pipeline/

Flaxman, S., Mishra, S., Gandy, A., Unwin, H., Coupland, H., Mellan, T., Zhu, H., Berah, T., Eaton, J., Perez Guzman, P., Schmit, N., Cilloni, L., Ainslie, K., Baguelin, M., Blake, I., Boonyasiri, A., Boyd, O., Cattarino, L., Ciavarella, C., … Bhatt, S. (2020). Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries. Imperial College London. https://doi.org/10.25561/77731

Fosmire, J. A., Hwang, K. y Makino, S. (1992). Identification and characterization of a coronavirus packaging signal. Journal of Virology, 66(6), 3522-3530. https://jvi.asm.org/content/66/6/3522

Fraga-Silva, R. A., Da Silva, D. G., Montecucco, F., Mach, F., Stergiopulos, N., Da Silva, R. F. y Santos, R. A. S. (2012). The angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas receptor axis: A potential target for treating thrombotic diseases. Thrombosis and haemostasis. https://doi.org/10.1160/TH12-06-0396

Franch Sarto, M. (2019). Bioinformática funcional y su aplicación en genómica, proteogenómica y reposicionamiento de fármacos [Tesis doctoral, Universidad Complutense de Madrid]. https://eprints.ucm.es/55758/

Freyer, F. J., Stout, M. y Finucane, M. (10 de marzo de 2020). Baker declares state of emergency as coronavirus cases more than double. The Boston Globe. https://www.bostonglobe.com/2020/03/10/metro/mass-legislative-leaders-propose-15-million-coronavirus-package/

Fu, B., Xu, X. y Wei, H. (2020). Why tocilizumab could be an effective treatment for severe COVID-19? Journal of Translational Medicine, 18(1), 164. https://doi.org/10.1186/s12967-020-02339-3

Fukui, M. y Furukawa, C. (2020). Power Laws in Superspreading Events: Evidence from Coronavirus Outbreaks and Implications for SIR Models. medRxiv. https://doi.org/10.1101/2020.06.11.20128058

Fundación Gabo. (2020). Epidemiología urgente para periodistas. https://drive.google.com/file/d/1dDRK7WSMXdIf94xQ6Md6n1r-fwbFMvas/view

Fundéu. (s. f.). Coronavirus. Todas nuestras recomendaciones lingüísticas sobre este asunto. https://fundeu.es/coronavirus-recomendaciones-lenguaje/

Fundéu. (27 de febrero de 2020). Coronavirus, claves de escritura. https://www.fundeu.es/recomendacion/coronavirus-claves-de-escritura/

Fundéu. (16 de marzo de 2020). La Fundéu y la crisis del coronavirus. https://www.fundeu.es/blog/la-fundeu-y-la-crisis-del-coronavirus/

Fundéu. (25 de marzo de 2020). «Vacuna contra la COVID-19», mejor que «contra el coronavirus». https://www.fundeu.es/recomendacion/vacuna-contra-la-covid-19/

Gaebler, C. y Nussenzweig, M. C. (2020). All eyes on a hurdle race for a SARS-CoV-2 vaccine. Nature, 586(7830), 501-502. https://doi.org/10.1038/d41586-020-02926-w

Galván, J. M., Rajas, O. y Aspa, J. (2015). Revisión sobre las infecciones no bacterianas del aparato respiratorio: Neumonías víricas. Archivos de Bronconeumología, 51(11), 590-597. https://doi.org/10.1016/j.arbres.2015.02.015

Gandhi, M. y Havlir, D. (2020). The Time for Universal Masking of the Public for Coronavirus Disease 2019 Is Now. Open Forum Infectious Diseases, 7(4), ofaa131. https://doi.org/10.1093/ofid/ofaa131

Gao, Y., Yan, L., Huang, Y., Liu, F., Zhao, Y., Cao, L., Wang, T., Sun, Q., Ming, Z., Zhang, L., Ge, J., Zheng, L., Zhang, Y., Wang, H., Zhu, Y., Zhu, C., Hu, T., Hua, T., Zhang, B., … Rao, Z. (2020). Structure of the RNA-dependent RNA polymerase from COVID-19 virus. Science, eabb7498. https://doi.org/10.1126/science.abb7498

Garrido-Hermosilla, A. M., Caro-Magdaleno, M., Moreno-Galdo, J. F. y Rodríguez-de-la-Rúa-Franch, E. (2020a, abril 27). Auditoría inmunitaria de COVID-19 en el servicio de oftalmología de un hospital de tercer nivel antes del desconfinamiento. http://www.sciencedirect.com/science/article/pii/S0365669120301349

Garrido-Hermosilla, A. M., Caro-Magdaleno, M., Moreno-Galdo, J. F. y Rodríguez-de-la-Rúa-Franch, E. (2020b). Immune audit of COVID-19 at the department of ophthalmology of a tertiary hospital before deconfinement. Archivos de la Sociedad Española de Oftalmología (English Edition), 95(6), 311-312. https://doi.org/10.1016/j.oftale.2020.04.002

Gavidia, M. (11 de marzo de 2020). Lung Volume Reduction Coil Treatment Enables Recovery in Severe COPD Cases. AJMC. https://www.ajmc.com/newsroom/lung-volume-reduction-coil-treatment-enables-recovery-in-severe-copd-cases

GeneTex. (2020). SARS-CoV-2 (COVID-19) [Catálogo]. https://www.lubio.ch/assets/PDFs/GeneTex_SARS-CoV-2_brochure_2020_original.pdf

Georgia Institute of Technology. (s. f.). GeneMark. Recuperado el 3 de mayo de 2020 en http://opal.biology.gatech.edu/GeneMark/

Georgia Institute of Technology. (s. f.). GeneMarkS (versión 4.28) [Programa informático]. Recuperado el 3 de mayo de 2020 en http://opal.biology.gatech.edu/genemark/genemarks.cgi

Gibbs, A. J., Gibbs, M. J. y Armstrong, J. S. (2004). The phylogeny of SARS coronavirus. Archives of Virology, 149(3), 621-624. https://doi.org/10.1007/s00705-003-0244-0

Gibbs, A. R. y Attanoos, R. L. (2018). 18—Environmental- and Toxin-Induced Lung Diseases. En D. S. Zander y C. F. Farver (eds.), Pulmonary Pathology (Second Edition) (pp. 374-395). Elsevier. https://doi.org/10.1016/B978-0-323-39308-9.00018-2

Giordano, P. (26 de febrero de 2020). Coronavirus: matemática del contagio para mantener la calma en medio del caos. El Mundo. https://www.elmundo.es/ciencia-y-salud/salud/2020/02/26/5e5626cafdddff4f768b4571.html

Girbes Juan, T. (13 de abril de 2020). Fusídico y cloroquina. Real Academia Nacional de Farmacia. https://www.ranf.com/noticia/fusidico-y-cloroquina/

Glavin, T. (7 de mayo de 2020). Footprints of the coronavirus: How it came to Canada and went around the world. Maclean’s. https://www.macleans.ca/society/health/footprints-of-the-coronavirus-how-it-came-to-canada-and-went-around-the-world/

Gobierno de España. Ministerio de Sanidad, Consumo y Bienestar Social. (s. f.). Enfermedad por nuevo coronavirus, COVID-19. https://www.mscbs.gob.es/en/profesionales/saludPublica/ccayes/alertasActual/nCov-China/situacionActual.htm

Goldhill, D. R., Imhoff, M., McLean, B. y Waldmann, C. (2007). Rotational Bed Therapy to Prevent and Treat Respiratory Complications: A Review and Meta-Analysis. American Journal of Critical Care, 16(1), 50-61. https://doi.org/10.4037/ajcc2007.16.1.50

Gomase, V., Tagore, S., Kale, K. y Bhiwgade, D. (2008). Oncogenomics. Current Drug Metabolism, 9(3), 199-206. https://doi.org/10.2174/138920008783884713

Gómez Esquivel, P. (2016). Primer caso clínico de lepra lepromatosis en costa rica. Revista Médica de Costa Rica y Centroamérica, 73(618), 179-184. https://www.medigraphic.com/pdfs/revmedcoscen/rmc-2016/rmc161zj.pdf

Gómez Polledo, P. (25 de marzo de 2020). ‘Coronaglosario’, glosario inglés-español sobre coronavirus y covid-19. BioMedicalTranslations.com. https://biomedicaltranslations.com/coronaglosario-glosario-ingles-espanol-sobre-coronavirus-y-covid-19/

Gómez-Gutiérrez, A. M., Parra-Sosa, B. E. y Bueno-Sánchez, J. C. (2013). Papel del receptor 1 de transferrina en la captación del hierro y su relación con la deficiencia gestacional de hierro y la preeclampsia. Revista Cubana de Obstetricia y Ginecología, 39(1), 33-42. http://scielo.sld.cu/pdf/gin/v39n1/gin05113.pdf

González-Romo, F. y Picazo, J. J. (2015). El desarrollo de nuevas vacunas. Enfermedades Infecciosas y Microbiología Clínica, 33(8), 557-568. https://doi.org/10.1016/j.eimc.2015.06.013

Gorbalenya, A. E., Baker, S. C., Baric, R. S., de Groot, R. J., Drosten, C., Gulyaeva, A. A., Haagmans, B. L., Lauber, C., Leontovich, A. M., Neuman, B. W., Penzar, D., Perlman, S., Poon, L. L. M., Samborskiy, D. V., Sidorov, I. A., Sola, I., Ziebuhr, J. y Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. (2020). The species Severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nature Microbiology, 5(4), 536-544. https://doi.org/10.1038/s41564-020-0695-z

Graff, G. (4 de marzo de 2020). New Yorkers, Once Again at Ground Zero, in Their Own Words. Wired. https://www.wired.com/story/new-yorkers-once-again-at-ground-zero-in-their-own-words/

Greenberg, N., Docherty, M., Gnanapragasam, S. y Wessely, S. (2020). Managing mental health challenges faced by healthcare workers during covid-19 pandemic. BMJ, 368, m1211. https://doi.org/10.1136/bmj.m1211

Grillo, K., Ocaña, L., Rodrigo, G. y Santaella-Tenorio, J. (2020). Mathematical models and the coronavirus, COVID-19. Colombia Medica. https://doi.org/10.25100/cm.v51i2.4277

Guerrero-Nancuante, C. y Manríquez, R. (2020). Proyección epidemiológica de COVID-19 en Chile basado en el modelo SEIR generalizado y el concepto de recuperado. Medwave, 20(04). https://doi.org/10.5867/medwave.2020.04.7898

Guidelines on the Use of Disinfectants. (31 de octubre de 2011). Recuperado el 5 de septiembre de 2020 en https://www.ipswichma.gov/DocumentCenter/View/10072/50ppm-Guidelines-on-the-Use-of-Disinfectants

Guirao Piñera, A. (2020). Entender una epidemia El coronavirus en España, situación y escenarios. Revista Española de Física, 34(2), 3-10. http://www.revistadefisica.es/index.php/ref/article/view/2659

Gunthe, S. S., Swain, B., Patra, S. S. y Amte, A. (2020). On the global trends and spread of the COVID-19 outbreak: Preliminary assessment of the potential relation between location-specific temperature and UV index. Journal of Public Health. https://doi.org/10.1007/s10389-020-01279-y

Guo, Y.-R., Cao, Q.-D., Hong, Z.-S., Tan, Y.-Y., Chen, S.-D., Jin, H.-J., Tan, K.-S., Wang, D.-Y. y Yan, Y. (2020). The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak – an update on the status. Military Medical Research, 7(1), 11. https://doi.org/10.1186/s40779-020-00240-0

Gupta, R., Pandey, G., Chaudhary, P. y Pal, S. K. (2020). SEIR and Regression Model based COVID-19 outbreak predictions in India. medRxiv. https://doi.org/10.1101/2020.04.01.20049825

Haddow, G. y Bullock, J. (2003). Introduction to Emergency Management. Butterworth-Heinemann.

Haentjens, P., Meerhaeghe, A. V., Poppe, K. y Velkeniers, B. (2008). Subclinical thyroid dysfunction and mortality: An estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. European Journal of Endocrinology, 159(3), 329-341. https://doi.org/10.1530/EJE-08-0110

Hamed, M. A. (2020). An overview on COVID-19: Reality and expectation. Bulletin of the National Research Centre, 44(1), 86. https://doi.org/10.1186/s42269-020-00341-9

Hans News Service. (20 de marzo de 2020). Visakhapatnam: Tourism Minister Muttamsetti Srinivasa Rao blames Naidu for postponement of local body polls. The Hans India. https://www.thehansindia.com/andhra-pradesh/visakhapatnam-tourism-minister-muttamsetti-srinivasa-rao-blames-naidu-for-postponement-of-local-body-polls-612948

Harapan, H., Itoh, N., Yufika, A., Winardi, W., Keam, S., Te, H., Megawati, D., Hayati, Z., Wagner, A. L. y Mudatsir, M. (2020). Coronavirus disease 2019 (COVID-19): A literature review. Journal of Infection and Public Health, 13(5), 667-673. https://doi.org/10.1016/j.jiph.2020.03.019

Hasan, A., Paray, B. A., Hussain, A., Qadir, F. A., Attar, F., Aziz, F. M., Sharifi, M., Derakhshankhah, H., Rasti, B., Mehrabi, M., Shahpasand, K., Saboury, A. A. y Falahati, M. (2020). A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin. Journal of Biomolecular Structure and Dynamics, 1-9. https://doi.org/10.1080/07391102.2020.1754293

He, F., Deng, Y. y Li, W. (2020). Coronavirus Disease 2019 (COVID‐19): What we know? Journal of Medical Virology, 1-7. https://doi.org/10.1002/jmv.25766

He, J., Tao, H., Yan, Y., Huang, S.-Y. y Xiao, Y. (2020). Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2. Viruses, 12(4), 428. https://doi.org/10.3390/v12040428

He, R., Lu, Z., Zhang, L., Fan, T., Xiong, R., Shen, X., Feng, H., Meng, H., Lin, W., Jiang, W. y Geng, Q. (2020). The clinical course and its correlated immune status in COVID-19 pneumonia. Journal of Clinical Virology, 127, 104361. https://doi.org/10.1016/j.jcv.2020.104361

Henderson, E. (28 de abril de 2020). Ayurveda and yoga could provide an effective, affordable means for COVID-19 prevention. News-Medical.Net. https://www.news-medical.net/news/20200428/Ayurveda-and-yoga-could-provide-an-effective-affordable-means-for-COVID-19-prevention.aspx

Hernández Santiago, R. (2019). Aislamiento y caracterización parcial de bacteriófagos de Salmonella spp con potencial aplicación en el biocontrol sobre superficies [Tesis doctoral. Facultat de Veterinària. Universitat Autònoma de Barcelona]. https://ddd.uab.cat/pub/tesis/2019/hdl_10803_667337/rhs1de1.pdf

Hicks, J. P. (17 de abril de 2020). Medical experts say Michigan’s coronavirus death count isn’t accurate. But is it too high or too low? Mlive.com. https://www.mlive.com/public-interest/2020/04/medical-experts-say-michigans-coronavirus-death-count-isnt-accurate-but-is-it-too-high-or-too-low.html

Hill, B. (2020). Coronavirus: Origins, signs, prevention and management of patients. British Journal of Nursing, 29(7), 399-402. https://doi.org/10.12968/bjon.2020.29.7.399

Hill-Cawthorne, G. (3 de febrero de 2020). Coronavirus – here’s what we know so far. The House. https://www.politicshome.com/thehouse/article/coronavirus–heres-what-we-know-so-far

Hodcroft, E. B., Zuber, M., Nadeau, S., Comas, I., Candelas, F. G., Consortium, S.-S., Stadler, T. y Neher, R. A. (2020). Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020. medRxiv. https://doi.org/10.1101/2020.10.25.20219063

Holmes, K. V. (1999). CORONAVIRUSES (CORONAVIRIDAE). En Encyclopedia of Virology, 291-298. Recuperado el 15 de abril de 2020 en https://doi.org/10.1006/rwvi.1999.0055

Hossny, E. y El-Owaidy, R. (2020). COVID-19 in children: Current data and future perspectives. The Egyptian Journal of Pediatric Allergy and Immunology, 18(1), 3-9. https://dx.doi.org/10.21608/ejpa.2020.81765

Hotez, P. J., Corry, D. B. y Bottazzi, M. E. (2020). COVID-19 vaccine design: The Janus face of immune enhancement. Nature Reviews Immunology, 20(6), 347-348. https://doi.org/10.1038/s41577-020-0323-4

HSE. (28 de marzo de 2020). HSE outlines main cocooning measures. https://www.hse.ie/eng/services/news/media/pressrel/hse-outlines-main-cocooning-measures.html

Huang, F., Li, Y., Leung, E. L.-H., Liu, X., Liu, K., Wang, Q., Lan, Y., Li, X., Yu, H., Cui, L., Luo, H. y Luo, L. (2020). A review of therapeutic agents and Chinese herbal medicines against SARS-CoV-2 (COVID-19). Pharmacological Research, 158, 104929. https://doi.org/10.1016/j.phrs.2020.104929

Hui, D. S. C. (2014). Noninvasive Ventilation in Patients with Severe Acute Respiratory Syndrome. En A. M. Esquinas (ed.), Noninvasive Ventilation in High-Risk Infections and Mass Casualty Events (pp. 129-137). Springer Vienna. https://doi.org/10.1007/978-3-7091-1496-4_13

Huitema, C., Zhang, J., Yin, J., James, M. N. G., Vederas, J. C. y Eltis, L. D. (2008). Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action. Bioorganic & Medicinal Chemistry, 16(10), 5761-5777. https://doi.org/10.1016/j.bmc.2008.03.059

Human Vaccines & Immunotherapeutics: news. (14 de abril de 2020). Human Vaccines & Immunotherapeutics, 16(4), 740-741. https://doi.org/10.1080/21645515.2020.1747917

Hyeon, J.-Y. (2013). A Foodborne Outbreak of Staphylococcus aureus Associated with Fried Chicken in Republic of Korea. Journal of Microbiology and Biotechnology, 23(1), 85-87. https://doi.org/10.4014/jmb.1210.10022

Iacobucci, G. (2020). Covid-19: GPs have a fortnight to start organising weekly care home reviews, says NHS. BMJ, 369, m1827. https://doi.org/10.1136/bmj.m1827

Ibáñez Ferrándiz, I. (2006). Bioterrorismo: La amenaza latente. CEU.

IDM Docs. (s. f.). SIR and SIRS models. Institute for Disease Modeling. https://idmod.org/docs/general/model-sir.html#sirs-model

Igenomix. (s. f.). What is the Carrier Screening Test? CGT Carrier Genetic Test Igenomix. Recuperado el 13 de abril de 2020 en https://cgt.igenomix.com/what-is-the-compatibility-genetic-test/

Imada, K. (1 de junio de 2020). How to wash and care for your reusable cloth face masks. Time Out Tokyo. https://www.timeout.com/tokyo/news/how-to-wash-and-care-for-your-reusable-cloth-face-masks-060120

Increasing number of COVID-19 patients shows govt’s incompetence: PPP leader. (5 de mayo de 2020). Daily Times. https://dailytimes.com.pk/607547/increasing-number-of-covid-19-patients-shows-govts-incompetence-ppp-leader/

Ingenix. (2002). Ingenix Coding Lab 2: Physician Offices 2003. Delmar Cengage Learning.

Inglesby, T. V. (2020). Public Health Measures and the Reproduction Number of SARS-CoV-2. JAMA, 323(21), 2186. https://doi.org/10.1001/jama.2020.7878

International Committee on Taxonomy of Viruses (ICTV) (2020). ICTV Master Species List 2018b.v2 [archivo Excel]. https://talk.ictvonline.org/files/master-species-lists/m/msl/8266

Ioannidis, J. P. A. (2020). Infection fatality rate of COVID-19 inferred from seroprevalence data. Bulletin of the World Health Organization. Publicación anticipada en línea. https://www.who.int/bulletin/online_first/BLT.20.265892.pdf

Ip, V. H. Y., Sondekoppam, R. V., Özelsel, T. J. P. y Tsui, B. C. H. (2020). COVID-19 Pandemic: International Variation of Personal Protective Equipment and Infection Prevention and Control Guidelines. Anesthesia & Analgesia, 131(2), e113-e114. https://doi.org/10.1213/ANE.0000000000004941

Iqbal, H. M., Romero-Castillo, K. D., Bilal, M. y Parra-Saldívar, R. (2020). The emergence of novel-coronavirus and its replication cycle – An overview. Journal of Pure and Applied Microbiology, 14, 13-16. https://doi.org/10.22207/JPAM.14.1.03

Ishige, T., Murata, S., Taniguchi, T., Miyabe, A., Kitamura, K., Kawasaki, K., Nishimura, M., Igari, H. y Matsushita, K. (2020). Highly sensitive detection of SARS-CoV-2 RNA by multiplex rRT-PCR for molecular diagnosis of COVID-19 by clinical laboratories. Clinica Chimica Acta, 507, 139-142. https://doi.org/10.1016/j.cca.2020.04.023

Issa, E., Merhi, G., Panossian, B., Salloum, T. y Tokajian, S. (2020). SARS-CoV-2 and ORF3a: Nonsynonymous Mutations, Functional Domains, and Viral Pathogenesis. MSystems, 5(3), e00266-20, /msystems/5/3/msys.00266-20.atom. https://doi.org/10.1128/mSystems.00266-20

Iwasaki, A. y Yang, Y. (2020). The potential danger of suboptimal antibody responses in COVID-19. Nature Reviews Immunology, 20(6), 339-341. https://doi.org/10.1038/s41577-020-0321-6

Iyer, M., Jayaramayya, K., Subramaniam, M. D., Lee, S. B., Dayem, A. A., Cho, S.-G. y Vellingiri, B. (2020). COVID-19: An update on diagnostic and therapeutic approaches. BMB Reports, 53(4), 191-205. https://doi.org/10.5483/BMBRep.2020.53.4.080

Jackman, C. (25 de marzo de 2020). A vast web of goodwill: Support acts restoring unity in the community. The New Daily. https://thenewdaily.com.au/life/2020/03/26/acts-of-kindness-restoring-unity-community/

Jain, J., Gaur, S., Chaudhary, Y. y Kaul, R. (2020). The molecular biology of intracellular events during Coronavirus infection cycle. VirusDisease, 31(2), 75-79. https://doi.org/10.1007/s13337-020-00591-1

Jayandharan, G. R. (ed.). (2018). Gene and Cell Therapy: Biology and Applications. Springer Singapore. https://doi.org/10.1007/978-981-13-0481-1

Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D. y Kim, S. (2020). Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs. Antimicrobial Agents and Chemotherapy, 64(7), e00819-20. https://doi.org/10.1128/AAC.00819-20

Jia, H. P., Look, D. C., Shi, L., Hickey, M., Pewe, L., Netland, J., Farzan, M., Wohlford-Lenane, C., Perlman, S. y McCray, P. B. (2005). ACE2 Receptor Expression and Severe Acute Respiratory Syndrome Coronavirus Infection Depend on Differentiation of Human Airway Epithelia. Journal of Virology, 79(23), 14614-14621. https://doi.org/10.1128/JVI.79.23.14614-14621.2005

Jiang, Z. y Thayumanavan, S. (2020). Noncationic Material Design for Nucleic Acid Delivery. Advanced Therapeutics, 3(3), 1900206. https://doi.org/10.1002/adtp.201900206

Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of M^pro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289-293. https://doi.org/10.1038/s41586-020-2223-y

Jones, A. M. (15 de febrero de 2020). Is your pet at risk of catching the novel coronavirus? CTVNews. https://www.ctvnews.ca/health/is-your-pet-at-risk-of-catching-the-novel-coronavirus-1.4813624

Juretic, D., Zucic, D., Jeroncic, A., Zoranic, L. y Bojovic, V. (s. f.). SPLIT 4.0 SERVER. Membrane protein secondary structure prediction server [Programa informático]. http://split.pmfst.hr/split/4/

Kakodkar, P., Kaka, N. y Baig, M. (2020). A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus, 12(4), e7560. https://doi.org/10.7759/cureus.7560

Kakodkar, P., Kaka, N. y Baig, M. N. (2020). A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus, 12(4): e7560. https://doi.org/10.7759/cureus.7560

Kalokairinou, L., Zettler, P. J., Nagappan, A., Kyweluk, M. A. y Wexler, A. (2020). The promise of direct-to-consumer COVID-19 testing: Ethical and regulatory issues. Journal of Law and the Biosciences. https://doi.org/10.1093/jlb/lsaa069

Kam, Y.-W., Okumura, Y., Kido, H., Ng, L. F. P., Bruzzone, R. y Altmeyer, R. (2009). Cleavage of the SARS Coronavirus Spike Glycoprotein by Airway Proteases Enhances Virus Entry into Human Bronchial Epithelial Cells In Vitro. PLoS ONE, 4(11), e7870. https://doi.org/10.1371/journal.pone.0007870

Kampf, G. (2020). Potential role of inanimate surfaces for the spread of coronaviruses and their inactivation with disinfectant agents. Infection Prevention in Practice, 2(2), 100044. https://doi.org/10.1016/j.infpip.2020.100044

Kampf, G., Todt, D., Pfaender, S. y Steinmann, E. (2020). Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. The Journal of Hospital Infection, 104(3), 246-251. https://doi.org/10.1016/j.jhin.2020.01.022

Kang, Y. y Xu, S. (2020). Comprehensive overview of COVID ‐19 based on current evidence. Dermatologic Therapy, 33(5), e13525. https://doi.org/10.1111/dth.13525

Kaplan, M. M. y Koprowski, H. (eds.). (1975). La rabia. Técnicas de laboratorio (3.ª ed.). Serie de monografías, n.º 23. Organización Mundial de la Salud. https://apps.who.int/iris/bitstream/handle/10665/41368/9243400231_spa.pdf#page=101

Kaszab, E., Lengyel, G., Marton, S., Dán, Á., Bányai, K. y Fehér, E. (2020). Occurrence and genetic diversity of CRESS DNA viruses in wild birds: A Hungarian study. Scientific Reports, 10, 7036. https://doi.org/10.1038/s41598-020-63795-x

KFF. (s. f.). Coronavirus (COVID-19) Outbreak Glossary. https://www.kff.org/glossary/covid-19-outbreak-glossary/

Khan, S., Siddique, R., Shereen, M. A., Ali, A., Liu, J., Bai, Q., Bashir, N. y Xue, M. (2020). Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options. Journal of Clinical Microbiology, 58(5), e00187-20, /jcm/58/5/JCM.00187-20.atom. https://doi.org/10.1128/JCM.00187-20

Kim, D., Lee, J.-Y., Yang, J.-S., Kim, J. W., Kim, V. N. y Chang, H. (2020). The Architecture of SARS-CoV-2 Transcriptome. Cell, 181(4), 914-921.e10. https://doi.org/10.1016/j.cell.2020.04.011

Kim, J. y Easley, C. J. (2011). Isothermal DNA amplification in bioanalysis: Strategies and applications. Bioanalysis, 3(2), 227-239. https://doi.org/10.4155/bio.10.172

Kirkeby, C., Halasa, T., Gussmann, M., Toft, N. y Græsbøll, K. (2017). Methods for estimating disease transmission rates: Evaluating the precision of Poisson regression and two novel methods. Scientific Reports, 7, 9496. https://doi.org/10.1038/s41598-017-09209-x

Kobayashi, L. M., Ramos Marins, B., Dos Santos Costa, P., Perazzo, H. y Castro, R. (2020). Extended use or reuse of N95 respirators during COVID-19 pandemic: An overview of national regulatory authority recommendations. Infection Control & Hospital Epidemiology, 41(11), 1364-1366. https://doi.org/10.1017/ice.2020.173

Kochhar, S., Excler, J.-L., Kim, D., Robertson, J. S., Fast, P. E., Condit, R. C., Drew, S., Wood, D., Gurwith, M., Klug, B., Whelan, M., Khuri-Bulos, N., Mallett Moore, T., Smith, E. R. y Chen, R. T. (2020). The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of inactivated viral vaccines. Vaccine, 38(39), 6184-6189. https://doi.org/10.1016/j.vaccine.2020.07.028

Kochhar, S., Kim, D., Excler, J.-L., Condit, R. C., Robertson, J. S., Drew, S., Whelan, M., Wood, D., Fast, P. E., Gurwith, M., Klug, B., Khuri-Bulos, N., Smith, E. R. y Chen, R. T. (2020). The Brighton Collaboration standardized template for collection of key information for benefit-risk assessment of protein vaccines. Vaccine, 38(35), 5734-5739. https://doi.org/10.1016/j.vaccine.2020.06.044

Kolifarhood, G., Aghaali, M., Mozafar Saadati, H., Taherpour, N., Rahimi, S., Izadi, N. y Hashemi Nazari, S. S. (2020). Epidemiological and Clinical Aspects of COVID-19; a Narrative Review. Archives of Academic Emergency Medicine, 8(1), e41. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7117787/

Koppers-Lalic, D., Hogenboom, M. M., Middeldorp, J. M. y Pegtel, D. M. (2013). Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine. Advanced Drug Delivery Reviews, 65(3), 348-356. https://doi.org/10.1016/j.addr.2012.07.006

Krebs, J. E., Goldstein, E. S. y Kilpatrick, S. T. (2020). Lewin’s Essential GENES. Jones & Bartlett Learning.

Kuo, L. y Masters, P. S. (2003). The Small Envelope Protein E Is Not Essential for Murine Coronavirus Replication. Journal of Virology, 77(8), 4597-4608. https://doi.org/10.1128/JVI.77.8.4597-4608.2003

LABline. (26 de febrero de 2020). Clinical trial of remdesivir to treat COVID-19 begins. Medical Laboratory Observer. https://www.mlo-online.com/disease/infectious-disease/article/21127143/clinical-trial-of-remdesivir-to-treat-covid19-begins

Labuda, J., Bowater, R. P., Fojta, M., Gauglitz, G., Glatz, Z., Hapala, I., Havliš, J., Kilar, F., Kilar, A., Malinovská, L., Sirén, H. M., Skládal, P., Torta, F., Valachovič, M., Wimmerová, M., Zdráhal, Z. y Hibbert, D. (2018). Terminology of bioanalytical methods (IUPAC Recommendations 2018), Pure and Applied Chemistry, 90(7), 1121-1198. https://doi.org/10.1515/pac-2016-1120

Lai, C.-C., Ko, W.-C., Lee, P.-I., Jean, S.-S. y Hsueh, P.-R. (2020). Extra-respiratory manifestations of COVID-19. International Journal of Antimicrobial Agents, 56(2), 106024. https://doi.org/10.1016/j.ijantimicag.2020.106024

Lai, C.-C., Shih, T.-P., Ko, W.-C., Tang, H.-J. y Hsueh, P.-R. (2020). Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International Journal of Antimicrobial Agents, 55(3), 105924. https://doi.org/10.1016/j.ijantimicag.2020.105924

Lake, M. A. (2020). What we know so far: COVID-19 current clinical knowledge and research. Clinical Medicine, 20(2), 124-127. https://doi.org/10.7861/clinmed.2019-coron

Latest Updates on the Coronavirus Disease. (28 de mayo de 2020). Interesting Engineering. https://interestingengineering.com/latest-updates-on-the-coronavirus-disease

Le, T. T., Andreadakis, Z., Kumar, A., Román, R. G., Tollefsen, S., Saville, M. y Mayhew, S. (2020). The COVID-19 vaccine development landscape. Nature Reviews Drug Discovery, 19(5), 305-306. https://doi.org/10.1038/d41573-020-00073-5

Leavitt, M. O. (13 de marzo de 2006). Pandemic planning update. Department of Health and Human Services. https://scholarworks.iupui.edu/bitstream/handle/1805/743/Pandemic%20planning%20update%20-%20DHHS%20-%20Leavitt.pdf?sequence=1

Lebreiro, A., Martins, E., Almeida, J., Pimenta, S., Bernardes, J. M., Machado, J. C. y Abreu-Lima, C. (2011). Utilidad del diagnóstico molecular en una familia con síndrome de Marfan y un fenotipo vascular atípico. Revista Española de Cardiología, 64(2), 151-154. https://doi.org/10.1016/j.recesp.2010.02.001

Lee, Y. J. (2 de abril de 2020). New data reveals coronavirus hotspots brewing across the south, where the pandemic is set to “hit hard”. Business Insider. https://www.businessinsider.com/coronavirus-hotspot-in-the-us-south-states-covid-19-pandemic-2020-4

Lefebvre, M. F., Hatta, Y., Bilsel, P. y Moser, M. J. (2015). Influenza virus vectors and uses therefor (World Intellectual Property Organization Patent N.^o WO2015142671). https://patentscope.wipo.int/search/en/detail.jsf?docId=WO2015142671

Lemay, G. (2018). Synthesis and Translation of Viral mRNA in Reovirus-Infected Cells: Progress and Remaining Questions. Viruses, 10(12), 671. https://doi.org/10.3390/v10120671

Lepelletier, D., Grandbastien, B., Romano-Bertrand, S., Aho, S., Chidiac, C., Géhanno, J.-F. y Chauvin, F. (2020). What face mask for what use in the context of the COVID-19 pandemic? The French guidelines. Journal of Hospital Infection, 105(3), 414-418. https://doi.org/10.1016/j.jhin.2020.04.036

Leung, H., Gunia, A. y Mansoor, S. (23 de enero de 2020). A Second Travel-Related Case of Coronavirus Has Been Confirmed in the U.S. Here’s What to Know. https://time.com/5759289/wuhan-pneumonia-outbreak-disease/

Leung, K., Wu, J. T., Liu, D. y Leung, G. M. (2020). First-wave COVID-19 transmissibility and severity in China outside Hubei after control measures, and second-wave scenario planning: A modelling impact assessment. The Lancet, 395(10233), 1382-1393. https://doi.org/10.1016/S0140-6736(20)30746-7

Li, C. y Xu, B. H. (2020). The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review. European review for medical and pharmacological sciences, 24(8), 4576-4584. https://doi.org/10.26355/eurrev_202004_21044

Li, L., Huang, T., Wang, Y., Wang, Z., Liang, Y., Huang, T., Zhang, H., Sun, W. y Wang, Y. (2020). COVID‐19 patients’ clinical characteristics, discharge rate, and fatality rate of meta‐analysis. Journal of Medical Virology, 92(6), 577-583. https://doi.org/10.1002/jmv.25757

Li, X., Geng, M., Peng, Y., Meng, L. y Lu, S. (2020). Molecular immune pathogenesis and diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10(2), 102-108. https://doi.org/10.1016/j.jpha.2020.03.001

Li, Y. y Xia, L. (2020). Coronavirus Disease 2019 (COVID-19): Role of Chest CT in Diagnosis and Management. American Journal of Roentgenology, 214(6), 1280-1286. https://doi.org/10.2214/AJR.20.22954

Liang, T. (ed.). (2020). Handbook of COVID-19 Prevention and Treatment. Zhejiang University School of Medicine. https://www.researchgate.net/publication/339998871_Handbook_of_COVID-19_Prevention_and_Treatment.

Liang, T. (ed.). (2020). Manual de prevención y tratamiento de COVID-19 (traducción). Zhejiang University School of Medicine. (Original publicado en 2020). https://www.sesst.org/wp-content/uploads/2020/04/manual-de-prevencion-y-tratamiento-de-covid-19-standard-spanish.pdf.pdf

Liao, L., Xiao, W., Zhao, M., Yu, X., Wang, H., Wang, Q., Chu, S. y Cui, Y. (2020). Can N95 Respirators Be Reused after Disinfection? How Many Times? ACS Nano, 14(5), 6348-6356. https://doi.org/10.1021/acsnano.0c03597

Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., Liu, L., Amit, I., Zhang, S. y Zhang, Z. (2020). Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19. Nature Medicine, 26(6), 842-844. https://doi.org/10.1038/s41591-020-0901-9

Lin, C., Chen, Z., Xie, B., Sun, Z., Ding, Y., Li, X., Niu, M., Guo, S. y Lei, J. (2020). COVID-19 pneumonia patient without clear epidemiological history outside Wuhan: An analysis of the radiographic and clinical features. Clinical Imaging, 65, 82-84. https://doi.org/10.1016/j.clinimag.2020.04.023

Lin, R. G. (17 de marzo de 2020). This coronavirus glossary will help you make sense of the pandemic. Los Angeles Times. https://gulf-times.com/story/659099

Liu, C., Yang, Y., Gao, Y., Shen, C., Ju, B., Liu, C., Tang, X., Wei, J., Ma, X., Liu, W., Xu, S., Liu, Y., Yuan, J., Wu, J., Liu, Z., Zhang, Z., Wang, P. y Liu, L. (2020). Viral Architecture of SARS-CoV-2 with Post-Fusion Spike Revealed by Cryo-EM. bioRxiv. https://doi.org/10.1101/2020.03.02.972927

Liu, D. y Zhao, J. (2018). Cytokine release syndrome: Grading, modeling, and new therapy. Journal of Hematology & Oncology, 11, 121. https://doi.org/10.1186/s13045-018-0653-x

Liu, Z., Magal, P., Seydi, O. y Webb, G. (2020). A COVID-19 epidemic model with latency period. Infectious Disease Modelling, 5, 323–337. https://doi.org/10.1016/j.idm.2020.03.003

López-Goñi, I. (22 de marzo de 2020). Antivirales y vacunas: la ayuda para frenar al coronavirus está en camino. The Conversation. https://theconversation.com/antivirales-y-vacunas-la-ayuda-para-frenar-al-coronavirus-esta-en-camino-134361

Lord, D. (18 de marzo de 2020). Coronavirus glossary: Some terms to know. Boston 25 News. https://www.boston25news.com/news/trending/coronavirus-glossary-some-terms-know/AFLQ6ORMY5FCJGJZPGAQDSUOUY/

Luján Galán, M., Páez Borda, Á., Llanes González, L., Romero Cajigal, I. y Berenguer Sánchez, A. (2020). Results of the Spanish section of the European Randomized Study of Screening for Prostate Cancer (ERSPC). Update after 21 years of follow-up. Actas Urológicas Españolas (English Edition), 44(6), 430-436. https://doi.org/10.1016/j.acuroe.2020.07.001

Luo, Y. R., Chakraborty, I., Yun, C., Wu, A. y Lynch, K. L. (2020). Kinetics of SARS-CoV-2 Antibody Avidity Maturation and Association with Disease Severity. Clinical infectious diseases, ciaa1389. Publicación anticipada en línea. https://doi.org/10.1093/cid/ciaa1389

Luthra, R., Singh, R. R. y Patel, K. P. (eds.). (2016). Clinical Applications of PCR (Vol. 1392). Springer New York. https://doi.org/10.1007/978-1-4939-3360-0

Lynch, J. y Smith, G. D. (2005). A life course approach to chronic disease epidemiology. Annual Review of Public Health, 26, 1-35. https://doi.org/10.1146/annurev.publhealth.26.021304.144505

Ma, Z. (2020). Spatiotemporal fluctuation scaling law and metapopulation modeling of the novel coronavirus (COVID-19) and SARS outbreaks. arXiv. http://arxiv.org/abs/2003.03714

Macera, C. A., Shaffer, R. y Shaffer, P. M. (2013). Introduction to Epidemiology: Distribution and Determinants of Disease. Cengage Learning.

Magal, A. (8 de febrero de 2020). Notes from the 560: Are we Corona ready? Bangalore Mirror. https://bangaloremirror.indiatimes.com/opinion/others/notes-from-the-560-are-we-corona-ready/articleshow/74015676.cms

Magnani, C., Azzolina, D., Gallo, E., Ferrante, D. y Gregori, D. (2020). How Large Was the Mortality Increase Directly and Indirectly Caused by the COVID-19 Epidemic? An Analysis on All-Causes Mortality Data in Italy. International Journal of Environmental Research and Public Health, 17(10), 3452. https://doi.org/10.3390/ijerph17103452

Mahase, E. (2020). Covid-19: First coronavirus was described in The BMJ in 1965. BMJ, 369, m1547. https://doi.org/10.1136/bmj.m1547

Malik, Y. A. (2020). Properties of Coronavirus and SARS-CoV-2. The Malaysian Journal of Pathology, 42(1), 3-11. http://www.mjpath.org.my/2020/v42n1/properties-of-coronavirus.pdf

Mannix, L. (28 de marzo de 2020). The perfect virus: Two gene tweaks that turned COVID-19 into a killer. The Age. https://www.theage.com.au/national/the-perfect-virus-two-gene-tweaks-that-turned-covid-19-into-a-killer-20200327-p54elo.html

Manohar, P., Loh, B., Nachimuthu, R., Hua, X., Welburn, S. C. y Leptihn, S. (2020). Secondary Bacterial Infections in Patients With Viral Pneumonia. Frontiers in Medicine, 7, 420. https://doi.org/10.3389/fmed.2020.00420

Manski, C. F. y Molinari, F. (2020). Estimating the COVID-19 infection rate: Anatomy of an inference problem. Journal of Econometrics [en prensa]. https://doi.org/10.1016/j.jeconom.2020.04.041

Marton, M. J. y Weiner, R. (2013). Practical Guidance for Implementing Predictive Biomarkers into Early Phase Clinical Studies. BioMed Research International, 891391. https://doi.org/10.1155/2013/891391

Mateo, K. F. (2020). How Does Telemedicine Compare to Conventional Follow-Up After General Surgery? Outcomes Research in Review, 27(3), 101-104. https://doi.org/10.12788/jcom.0003

Mateos Gómez, P. A. (2012). Síntesis discontinua de RNA en coronavirus [Tesis doctoral, Universidad Autónoma de Madrid]. https://repositorio.uam.es/xmlui/handle/10486/12013

Matrajt, L. y Leung, T. (2020). Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease. Emerging Infectious Diseases, 26(8), 1740-1748. https://doi.org/10.3201/eid2608.201093

McClements, F. (16 de abril de 2020). Coronavirus: Northern Ireland ‘at, or very close to’ peak of outbreak. The Irish Times. https://www.irishtimes.com/news/ireland/irish-news/coronavirus-northern-ireland-at-or-very-close-to-peak-of-outbreak-1.4230526

McFadden, S. M., Malik, A. A., Aguolu, O. G., Willebrand, K. S. y Omer, S. B. (2020). Perceptions of the adult US population regarding the novel coronavirus outbreak. PLOS ONE, 15(4), e0231808. https://doi.org/10.1371/journal.pone.0231808

Meeting assess state preparedness to tackle containment of COVID-19. (25 de marzo de 2020). The Morung Express. https://morungexpress.com/meeting-assess-state-preparedness-tackle-containment-covid-19

Menchero Sánchez, M. (2020). Flujos turísticos, geopolítica y COVID-19: Cuando los turistas internacionales son vectores de transmisión. Geopolítica(s). Revista de estudios sobre espacio y poder, 11(Especial), 105-114. https://doi.org/10.5209/geop.69249

Merrill, R. M. y Timmreck, T. C. (2006). Introduction to Epidemiology. Jones & Bartlett Learning.

Meylan, S., Akrour, R., Regina, J., Bart, P.-A., Dami, F. y Calandra, T. (28 de mayo de 2020). An Early Warning Score to predict ICU admission in COVID-19 positive patients. Elsevier. https://www.journalofinfection.com/article/S0163-4453(20)30324-8/abstract

Milewska, A., Nowak, P., Owczarek, K., Szczepanski, A., Zarebski, M., Hoang, A., Berniak, K., Wojarski, J., Zeglen, S., Baster, Z., Rajfur, Z. y Pyrc, K. (2018). Entry of Human Coronavirus NL63 into the Cell. Journal of Virology, 92(3). https://doi.org/10.1128/JVI.01933-17

Miller, R. y Englund, K. (2020). Clinical presentation and course of COVID-19. Cleveland Clinic Journal of Medicine, 87(7), 384-388. https://doi.org/10.3949/ccjm.87a.ccc013

Millet, J. K. y Whittaker, G. R. (2018). Physiological and molecular triggers for SARS-CoV membrane fusion and entry into host cells. Virology, 517, 3-8. https://doi.org/10.1016/j.virol.2017.12.015

Milton, D. K., Fabian, M. P., Cowling, B. J., Grantham, M. L. y McDevitt, J. J. (2013). Influenza Virus Aerosols in Human Exhaled Breath: Particle Size, Culturability, and Effect of Surgical Masks. PLOS Pathogens, 9(3), e1003205. https://doi.org/10.1371/journal.ppat.1003205

Milwid, R., Steriu, A., Arino, J., Heffernan, J., Hyder, A., Schanzer, D., Gardner, E., Haworth-Brockman, M., Isfeld-Kiely, H., Langley, J. M. y Moghadas, S. M. (2016). Toward Standardizing a Lexicon of Infectious Disease Modeling Terms. Frontiers in Public Health, 4, 213. https://doi.org/10.3389/fpubh.2016.00213

Miracle Mineral Supplement. (9 de abril de 2020). En Wikipedia. https://en.wikipedia.org/w/index.php?title=Miracle_Mineral_Supplement&oldid=949925407

ML Driven Epidemiological Model to Forecast COVID-19 Progression by Quantifying Interventions. (16 de junio de 2020).  Analytics India Magazine. https://analyticsindiamag.com/ml-driven-epidemiological-model-to-forecast-covid-19-progression-by-quantifying-interventions/

Mohseni, A. H., Taghinezhad-S, S., Xu, Z. y Fu, X. (2020). Body fluids may contribute to human-to-human transmission of severe acute respiratory syndrome coronavirus 2: Evidence and practical experience. Chinese Medicine, 15(1), 58. https://doi.org/10.1186/s13020-020-00337-7

Mole, B. (4 de mayo de 2020). Don’t Panic: The comprehensive Ars Technica guide to the coronavirus [Updated 4/5]. Ars Technica. https://arstechnica.com/science/2020/04/dont-panic-the-comprehensive-ars-technica-guide-to-the-coronavirus/

Molinero, E. A. (2016). Trabajo Final de Máster Profesional/Máster en Traducción Médico-Sanitaria [Universitat Jaume I]. http://repositori.uji.es/xmlui/bitstream/handle/10234/166092/TFM_2016_ArranzMolineroElena.pdf

Morilla, F. y Donado-Campos, J. (s. f.). Situaciones endémicas en enfermedades transmisibles. Recuperado el 15 de octubre de 2020 en http://www.dia.uned.es/~fmorilla/Web_FMorilla_Julio_2013/Ultimas_publicaciones/2005_SE_JA05.pdf

Mousavizadeh, L. y Ghasemi, S. (2020). Genotype and phenotype of COVID-19: Their roles in pathogenesis. Journal of microbiology, immunology, and infection, S1684-1182(20)30082-7. Publicación anticipada en línea. https://doi.org/10.1016/j.jmii.2020.03.022

Mullard, A. (2020). Flooded by the torrent: The COVID-19 drug pipeline. The Lancet, 395(10232), 1245-1246. https://doi.org/10.1016/S0140-6736(20)30894-1

Mulrooney, B., Kovack, S. E. y Kongelf, A. (13 de octubre de 2014). ‘A teenage girl bled to death over two days’: Ebola nurses describe life and death on the frontline. The Guardian. https://www.theguardian.com/world/2014/oct/13/ebola-nurses-describe-life-death-on-frontline-liberia-sierra-leone

Murphy, A. (20 de marzo de 2020). The hilarious new slang terms born from the coronavirus pandemic. Mail Online. https://www.dailymail.co.uk/femail/article-8133327/Australians-come-hilarious-list-new-slang-terms-born-coronavirus-pandemic.html

Mutar Mahdi, B. (2020). COVID-19 type III hypersensitivity reaction. Medical Hypotheses, 140, 109763. https://doi.org/10.1016/j.mehy.2020.109763

Naserghandi, A., Allameh, S. F. y Saffarpour, R. (2020). All about COVID-19 in brief. New Microbes and New Infections, 35, 100678. https://doi.org/10.1016/j.nmni.2020.100678

National Adult Literacy Agency. (21 de abril de 2020). Coronavirus (COVID-19) words and terms explained in plain English. https://www.nala.ie/covid-19-words-explained/

National Center for Biotechnology Information. (s. f.). BLAST: Basic Local Alignment Search Tool. Recuperado el 3 de mayo de 2020 en https://blast.ncbi.nlm.nih.gov/Blast.cgi

National Center for Biotechnology Information. (s. f.). Sodium hydroxide, CID=14798. En PubChem Database. Recuperado el 13 de abril de 2020 en https://pubchem.ncbi.nlm.nih.gov/compound/14798

National Health Service. (s. f.). Coronavirus (COVID-19): Shielding. NHS inform. https://www.nhsinform.scot/illnesses-and-conditions/infections-and-poisoning/coronavirus-covid-19/coronavirus-covid-19-shielding

National Institute of Allergy and Infectious Diseases. (s. f.). Immune Epitope Database and Analysis Resource (IEDB). https://www.iedb.org/

National Library of Medicine. LitCovid. (s. f.). Recuperado el 6 de agosto de 2020 en https://www.ncbi.nlm.nih.gov/research/coronavirus/

Navarro, F. (2 de abril de 2020). Coronavirus: Usos correctos. Diario médico. https://www.diariomedico.com/opinion/fernando-navarro/coronavirus-usos-correctos.html

Navarro, F. A. (2018). Qué hacemos en biomedicina con los neologismos ingleses acuñados por contracción?: bigorexia, botox, chemtrail, globesity, nutraceuticals, pharming, surfactant, tanorexia, tuppersex, tweenager, vacutainer, workaholic… En J. Sevilla Muñoz (coord.), Enfoques actuales de la traducción. Estudios dedicados a Valentín García Yebra [en línea]. Instituto Cervantes. https://cvc.cervantes.es/lengua/yebra/navarro.htm

Navarro, F. A. (24 de marzo de 2020). Glosario de siglas coronavíricas en español. Diario Médico. https://www.diariomedico.com/opinion/fernando-navarro/glosario-de-siglas-coronaviricas-en-espanol.html

Navarro, F. A. (13 de abril de 2020). Glosario de siglas coronavíricas en español. Diario Médico. https://www.diariomedico.com/opinion/fernando-navarro.html

NE NOW NEWS. (29 de abril de 2020). Home ministry allows inter-state movement of stranded people. Northeast Now. https://nenow.in/north-east-news/home-ministry-allows-inter-state-movement-of-lockdown-hit-people.html

Nelson, A. (15 de abril de 2020). Coronavirus vulnerable groups: Full list of people at risk from Covid-19 who should be «shielding» under UK advice. inews.co.uk. https://inews.co.uk/news/health/vulnerable-groups-coronavirus-at-risk-full-covid-19-shielding-uk-advice-government-latest-explained-2505741

Nikiforuk, A. (13 de abril de 2020). Deciding Who Gets Tested Differs across Canada, Causing ‘Chaos and Errors’. The Tyee. https://thetyee.ca/News/2020/04/13/Testing-Across-Canada/

North Carolina Biotechnology Center. COVID-19 Resources for North Carolina Life Science Companies and Researchers. https://www.ncbiotech.org/covid-19

Novel Coronavirus Disease (COVID-19). Contact tracing guidelines. (s. f.). Recuperado el 21 de junio de 2020 en https://extranet.who.int/goarn/sites/default/files/Novel%20Coronavirus%20Disease%20%28COVID-19%29.pptx.pdf

Occupational Safety and Health Administration. (s. f.). COVID-19. Standards. https://www.osha.gov/SLTC/covid-19/standards.html

Oficina Regional de la OIT para América Latina y el Caribe. (2012). The ILO in Latin America and The Caribbean. Advances 2010-2011 and Perspectives 2012-2013. Organización Internacional del Trabajo. https://www.ilo.org/wcmsp5/groups/public/—americas/—ro-lima/documents/publication/wcms_185122.pdf

Oney, A. (17 de marzo de 2020). “Close contact” and COVID-19: What does it mean? U. S. Army. https://www.army.mil/article/233827/close_contact_and_covid_19_what_does_it_mean

Oprea, T. I., Bauman, J. E., Bologa, C. G., Buranda, T., Chigaev, A., Edwards, B. S., Jarvik, J. W., Gresham, H. D., Haynes, M. K., Hjelle, B., Hromas, R., Hudson, L., Mackenzie, D. A., Muller, C. Y., Reed, J. C., Simons, P. C., Smagley, Y., Strouse, J., Surviladze, Z., … Sklar, L. A. (2011). Drug repurposing from an academic perspective. Drug Discovery Today: Therapeutic Strategies, 8(3), 61-69. https://doi.org/10.1016/j.ddstr.2011.10.002

Organización Mundial de la Salud. (2005). Manual de bioseguridad en el laboratorio (3ª ed.). https://www.who.int/topics/medical_waste/manual_bioseguridad_laboratorio.pdf

Organización Mundial de la Salud. (24 de febrero de 2010) ¿Qué es una pandemia? https://www.who.int/csr/disease/swineflu/frequently_asked_questions/pandemic/es/

Organización Mundial de la Salud. (2020). Protocol for assessment of potential risk factors for coronavirus disease 2019 (COVID-19) among health workers in a health care setting. https://apps.who.int/iris/bitstream/handle/10665/332071/WHO-2019-nCoV-HCW_risk_factors_protocol-2020.3-eng.pdf

Organización Mundial de la Salud. (30 de enero de 2020). International Health Regulations Emergency Committee on novel coronavirus in China. https://www.who.int/news-room/events/detail/2020/01/30/default-calendar/international-health-regulations-emergency-committee-on-novel-coronavirus-in-china

Organización Mundial de la Salud. (11 de febrero de 2020). WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-remarks-at-the-media-briefing-on-2019-ncov-on-11-february-2020

Organización Mundial de la Salud. (12 de febrero de 2020). Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19). https://apps.who.int/iris/bitstream/handle/10665/331138/WHO-WPE-GIH-2020.1-eng.pdf

Organización Mundial de la Salud. (2 de marzo de 2020). Laboratory Testing for Coronavirus Disease 2019 (COVID-19) in Suspected Human Cases. Interim Guidance. https://aslm.org/resource/laboratory-testing-for-coronavirus-disease-2019-covid-19-in-suspected-human-cases-interim-guidance-2-march-2020/

Organización Mundial de la Salud. (10 de marzo de 2020). The COVID-19 Risk Communication Package for Healthcare facilities. https://iris.wpro.who.int/bitstream/handle/10665.1/14482/COVID-19-022020.pdf

Organización Mundial de la Salud. (19 de marzo de 2020). Considerations for quarantine of individuals in the context of containment for coronavirus disease (COVID-19). Interim guidance. https://apps.who.int/iris/bitstream/handle/10665/331497/WHO-2019-nCoV-IHR_Quarantine-2020.2-eng.pdf

Organización Mundial de la Salud. (19 de marzo de 2020). Laboratory biosafety guidance related to coronavirus disease (‎‎COVID-19)‎‎. Interim guidance. https://apps.who.int/iris/handle/10665/331500

Ortega-Lenis, D., Arango-Londoño, D., Muñoz, E., Cuartas, D. E., Caicedo, D., Mena, J., Torres, M., Mendez, F., Ortega-Lenis, D., Arango-Londoño, D., Muñoz, E., Cuartas, D. E., Caicedo, D., Mena, J., Torres, M. y Mendez, F. (2020). Predictions of a SEIR model for COVID-19 cases in Cali-Colombia. Revista de Salud Pública, 22(2), 1-6. https://doi.org/10.15446/rsap.v22n2.86432

Osorio, L. (ed.). (2012). Diccionario de términos de salud español-inglés (4.^a ed.). Iniciativa de Salud de las Américas. https://hiaucb.files.wordpress.com/2014/03/dictionary-2011_spanish_pdf-version.pdf

Otter, J. A., Donskey, C., Yezli, S., Douthwaite, S., Goldenberg, S. D. y Weber, D. J. (2016). Transmission of SARS and MERS coronaviruses and influenza virus in healthcare settings: The possible role of dry surface contamination. Journal of Hospital Infection, 92(3), 235-250. https://doi.org/10.1016/j.jhin.2015.08.027

Ozaslan, M., Safdar, M., Kilic, I. H. y Khailany, R. A. (2020). Practical Measures to Prevent COVID-19: A Mini-Review. Journal of Biological Sciences, 20(2), 100-102. https://doi.org/10.3923/jbs.2020.100.102

Ozma, M. A., Maroufi, P., Khodadadi, E., Köse, Ş., Esposito, I., Ganbarov, K., Dao, S., Esposito, S., Dal, T., Zeinalzadeh, E. y Kafil, H. S. (2020). Clinical manifestation, diagnosis, prevention and control of SARS-CoV-2 (COVID-19) during the outbreak period. Le Infezioni in Medicina, 28(2), 153-165. https://www.infezmed.it/index.php/article?Anno=2020&numero=2&ArticoloDaVisualizzare=Vol_28_2_2020_153

Pandey, S. C., Pande, V., Sati, D., Upreti, S. y Samant, M. (2020). Vaccination strategies to combat novel corona virus SARS-CoV-2. Life Sciences, 256, 117956. https://doi.org/10.1016/j.lfs.2020.117956

Pardi, N. y Weissman, D. (2017). Nucleoside Modified mRNA Vaccines for Infectious Diseases. En T. Kramps y K. Elbers (eds.), RNA Vaccines (Vol. 1499, pp. 109-121). Springer New York. https://doi.org/10.1007/978-1-4939-6481-9_6

Park, J.-E., Cruz, D. J. M. y Shin, H.-J. (2014). Clathrin- and serine proteases-dependent uptake of porcine epidemic diarrhea virus into Vero cells. Virus Research, 191, 21-29. https://doi.org/10.1016/j.virusres.2014.07.022

Park, W., Shin, H., Choi, B., Rhim, W.-K., Na, K. y Keun Han, D. (2020). Advanced hybrid nanomaterials for biomedical applications. Progress in Materials Science, 114, 100686. https://doi.org/10.1016/j.pmatsci.2020.100686

Parkinson, N. (17 de marzo de 2020). Coronavirus’ impact on US industry. Gasworld. https://www.gasworld.com/coronavirus-impact-on-us-industry/2018619.article

Pascarella, G., Strumia, A., Piliego, C., Bruno, F., Del Buono, R., Costa, F., Scarlata, S. y Agrò, F. E. (2020). COVID-19 diagnosis and management: A comprehensive review. Journal of Internal Medicine, 288, 192-206. https://doi.org/10.1111/joim.13091

Pastick, K. A., Okafor, E. C., Wang, F., Lofgren, S. M., Skipper, C. P., Nicol, M. R., Pullen, M. F., Rajasingham, R., McDonald, E. G., Lee, T. C., Schwartz, I. S., Kelly, L. E., Lother, S. A., Mitjà, O., Letang, E., Abassi, M. y Boulware, D. R. (2020). Review: Hydroxychloroquine and Chloroquine for Treatment of SARS-CoV-2 (COVID-19). Open Forum Infectious Diseases, 7(4), ofaa130. https://doi.org/10.1093/ofid/ofaa130

Pattison, N. (2020). End-of-life decisions and care in the midst of a global coronavirus (COVID-19) pandemic. Intensive & Critical Care Nursing, 58, 102862. https://doi.org/10.1016/j.iccn.2020.102862

Pérez-Vázquez, D., Contreras-Castillo, E. y Licona-Limón, P. (2018). Memoria inmunológica innata, la pieza faltante de la respuesta inmunológica. TIP Revista Especializada En Ciencias Químico-Biológicas, 21(Supl. 1), 112-123. https://doi.org/10.22201/fesz.23958723e.2018.0.151

Perotti, C., Del Fante, C., Baldanti, F., Franchini, M., Percivalle, E., Vecchio Nepita, E., Seminari, E., De Silvestri, A., Bruno, R. y Klersy, C. (2020). Plasma from donors recovered from the new Coronavirus 2019 as therapy for critical patients with COVID-19 (COVID-19 plasma study): A multicentre study protocol. Internal and Emergency Medicine, 15(5), 819-824. https://doi.org/10.1007/s11739-020-02384-2

Perrotta, F., Matera, M. G., Cazzola, M. y Bianco, A. (2020). Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter? Respiratory Medicine, 168, 105996. https://doi.org/10.1016/j.rmed.2020.105996

Peterkin, T. y Ross, C. (2 de marzo de 2020). Coronavirus in Scotland: An in-depth look at what the first minister and chief medical officer said in their update. The Press and Journal. https://www.pressandjournal.co.uk/fp/news/politics/scottish-politics/2044604/coronavirus-in-scotland-an-in-depth-look-at-what-the-first-minister-and-chief-medical-officer-said-in-their-update-today/

Peterson, D., Damsky, W. y King, B. (2020). The use of Janus kinase inhibitors in the time of SARS-CoV-2. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2020.03.099

Phan, T. (2020). Genetic diversity and evolution of SARS-CoV-2. Infection, Genetics and Evolution, 81, 104260. https://doi.org/10.1016/j.meegid.2020.104260

Phan, T. (2020). Novel coronavirus: From discovery to clinical diagnostics. Infection, Genetics and Evolution, 79, 104211. https://doi.org/10.1016/j.meegid.2020.104211

Pickar-Oliver, A. y Gersbach, C. A. (2019). The next generation of CRISPR–Cas technologies and applications. Nature Reviews Molecular Cell Biology, 20(8), 490-507. https://doi.org/10.1038/s41580-019-0131-5

Piepenburg, O., Williams, C. H., Stemple, D. L. y Armes, N. A. (2006). DNA Detection Using Recombination Proteins. PLoS Biology, 4(7), e204. https://doi.org/10.1371/journal.pbio.0040204

Pillay, T. S. (2020). Gene of the month: The 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein. Journal of Clinical Pathology, 73(7), 366-369. https://doi.org/10.1136/jclinpath-2020-206658

Pinky, L. y Dobrovolny, H. M. (2020). SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial? Journal of Medical Virology, 92(11), 2623-2630. https://doi.org/10.1002/jmv.26098

Pithon, M. M., Ferraz, C. S., Rosa, F. C. S., Rosa, L. P., Pithon, M. M., Ferraz, C. S., Rosa, F. C. S. y Rosa, L. P. (2015). Sterilizing elastomeric chains without losing mechanical properties. Is it possible? Dental Press Journal of Orthodontics, 20(3), 96-100. https://doi.org/10.1590/2176-9451.20.3.096-100.oar

Pitocco, D., Tartaglione, L., Viti, L., Di Leo, M., Pontecorvi, A. y Caputo, S. (2020). SARS-CoV-2 and DPP4 inhibition: Is it time to pray for Janus Bifrons? Diabetes Research and Clinical Practice, 163, 108162. https://doi.org/10.1016/j.diabres.2020.108162

Pons Rodríguez, L. (8 de abril de 2020). «Covidiota», «balconazis», «cuarenpena»… Los neologismos que nos ha traído la pandemia. El País. https://verne.elpais.com/verne/2020/04/07/articulo/1586246728_179666.html

Pörtner, R. (ed.). (2007). Animal cell biotechnology: Methods and protocols (2. ed). Humana Press.

Pratt, R., Pellowe, C., Loveday, H., Robinson, N., Smith, G., Barrett, S., Davey, P., Harper, P., Loveday, C., McDougall, C., Mulhall, A., Privett, S., Smales, C., Taylor, L., Weller, B. y Wilcox, M. (2001). The epic Project: Developing National Evidence-based Guidelines for Preventing Healthcare associated Infections. Journal of Hospital Infection, 47(Supplement), S3-S4. https://doi.org/10.1053/jhin.2000.0886

Press Association. (2020). Household isolation, social distancing and shielding – who should do what? Isle of Wight County Press. https://www.countypress.co.uk/news/national/18312749.household-isolation-social-distancing-shielding–/

Priyanka, K., Sowdameni, T. y Mujeebuddin, C. S. (2020). Corona Virus—An Updated Review. International Journal of Pharmaceutical Sciences Review and Research, 61(1), 138-144. https://globalresearchonline.net/journalcontents/v61-1/23.pdf

ProMED (s. f.). Latest on COVID-19. International Society for Infectious Diseases. Recuperado el 13 de abril de 2020 en https://promedmail.org/coronavirus/

Public Health Agency of Canada. (2016). Canadian Biosafety Handbook (2ª ed.). https://www.canada.ca/content/dam/phac-aspc/migration/cbsg-nldcb/cbh-gcb/assets/pdf/cbh-gcb-eng.pdf

Quintin, J., Cheng, S.-C., Van der Meer, J. W. y Netea, M. G. (2014). Innate immune memory: Towards a better understanding of host defense mechanisms. Current Opinion in Immunology, 29, 1-7. https://doi.org/10.1016/j.coi.2014.02.006

Rabaan, A. A., Al-Ahmed, S. H., Haque, S., Sah, R., Tiwari, R., Malik, Y. S., Dhama, K., Yatoo, M. I., Bonilla-Aldana, D. K. y Rodriguez-Morales, A. J. (2020). SARS-CoV-2, SARS-CoV, and MERS-CoV: a comparative overview. Le Infezioni in Medicina, 28(2), 174-184. https://www.infezmed.it/index.php/article?Anno=2020&numero=2&ArticoloDaVisualizzare=Vol_28_2_2020_174

Rabold, E. y Waggoner, J. (2017). Chapter 11: Posttravel Evaluation. En Centers for Disease Control and Prevention (ed.). CDC Yellow Book 2020: Health Information for International Travel. Oxford University Press. https://wwwnc.cdc.gov/travel/yellowbook/2020/posttravel-evaluation/rapid-diagnostic-tests-for-infectious-diseases

Rampal, L. y Liew, B. S. (2020). Coronavirus disease (COVID-19) pandemic [Editorial]. Medical Journal of Malaysia, 75(2), 95-97. http://www.e-mjm.org/2020/v75n2/coronavirus-disease.pdf

Ranawana, A. (16 de junio de 2020). Sri Lanka COVID positive number closes in on the two thousand mark as repatriation flights continue. EconomyNext. https://economynext.com/sri-lanka-covid-positive-number-closes-in-on-the-two-thousand-mark-as-repatriation-flights-continue-71102/

Real Academia Española. (18 de marzo de 2020). Crisis del COVID-19: sobre la escritura de coronavirus. https://www.rae.es/noticias/crisis-del-covid-19-sobre-la-escritura-de-coronavirus

Redacción. (2020). Nota a los lectores. puntoycoma. Boletín de los traductores españoles de las instituciones de la Unión Europea, 165, 2. https://ec.europa.eu/translation/spanish/magazine/documents/pyc_165_es.pdf

Reina, J. (2020). El SARS-CoV-2, una nueva zoonosis pandémica que amenaza al mundo (en prensa). Vacunas. https://doi.org/10.1016/j.vacun.2020.03.001

Repici, A., Maselli, R., Colombo, M., Gabbiadini, R., Spadaccini, M., Anderloni, A., Carrara, S., Fugazza, A., Di Leo, M., Galtieri, P. A., Pellegatta, G., Ferrara, E. C., Azzolini, E. y Lagioia, M. (2020). Coronavirus (COVID-19) outbreak: What the department of endoscopy should know. Gastrointestinal Endoscopy, 92(1), 192-197. https://doi.org/10.1016/j.gie.2020.03.019

Resnick, B. (28 de marzo de 2020). Ventilator vs. respirator, quarantine vs. isolation: Covid-19 pandemic terms, defined. Vox. https://www.vox.com/science-and-health/2020/3/27/21190774/ventilator-respirator-quarantine-isolation-definitions-covid-19-pandemic-terms

Reyes, D. C. (2020). On Viruses, Coronaviruses, SARS-CoV-2 and COVID-19, and Pandemics.

Richardson, A., Bentley, D., Chamberlain, Z., Rodger, J., Haynes, J., birminghammail.co.uk, Paxton, C., Bains, S. y Balloo, S. (23 de marzo de 2020). Live updates: UK in lockdown as Prime Minister orders the country to stay at home. BirminghamLive. https://www.birminghammail.co.uk/news/midlands-news/coronavirus-live-updates-latest-news-17865835

Ridley, R. G. (2004). Research on infectious diseases requires better coordination. Nature Medicine, 10(12), S137-S140. https://doi.org/10.1038/nm1153

Right, E. (s. f.). This Podcast Will Kill You. COVID-19 Chapter 5: Vaccines. Recuperado el 26 de octubre de 2020 en https://www.globalplayer.com/podcasts/episodes/7Drb47x//

Rodgers, K. (31 de marzo de 2020). COVID-19 Healthcare Planning Checklist. National Association of County and City Health Officials (NACCHO). https://www.naccho.org/blog/articles/covid-19-healthcare-planning-checklist

Rodrigues, M., Ayabe, N. H., Lunardelli, M. C. F. y Canêo, L. C. (2005). A preparação para a aposentadoria: O papel do psicólogo frente a essa questão. Revista Brasileira de Orientação Profissional, 6(1), 53-62. http://pepsic.bvsalud.org/pdf/rbop/v6n1/v6n1a06.pdf

Rodriguez-Morales, A. J., Cardona-Ospina, J. A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., Holguin-Rivera, Y., Escalera-Antezana, J. P., Alvarado-Arnez, L. E., Bonilla-Aldana, D. K., Franco-Paredes, C., Henao-Martinez, A. F., Paniz-Mondolfi, A., Lagos-Grisales, G. J., Ramírez-Vallejo, E., Suárez, J. A., Zambrano, L. I., Villamil-Gómez, W. E., Balbin-Ramon, G. J., Rabaan, A. A., Harapan, H., … Sah, R. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease, 101623. https://doi.org/10.1016/j.tmaid.2020.101623

Rodríguez-Morales, A., Bonilla-Aldana, D.K., Tiwari, R., Sah, R., Rabaan, A.A. y Dhama, K. (2020). Covid-19, an emerging coronavirus infection: Current scenario and recent developments – An overview. Journal of Pure and Applied Microbiology, 14, 05-12. https://doi.org/10.22207/jpam.14.1.02

Romano, L. (15 de marzo de 2020). Glossary of COVID-19 Terms. NowDecatur. http://www.nowdecatur.com/2020/03/15/glossary-of-covid-19-terms/

Romero Cabello, R. (2018). Microbiología y Parasitología Humana: Bases etiológicas de las enfermedades infecciosas y parasitarias (4ª ed.). Editorial Médica Panamericana. https://www.medicapanamericana.com/es/libro/microbiologia-y-parasitologia-humana

Rosman, K. (16 de abril de 2020). ‘Corona-Shamed’: George Stephanopoulos, J. Lo — Maybe You? The New York Times. https://www.nytimes.com/2020/04/16/style/coronavirus-public-shaming.html

Ross, E. (14 de marzo de 2020). A Glossary of coronavirus terms, from ARDS to Zoonotic. OPB. https://www.opb.org/news/article/covid-19-coronavirus-glossary-medical-scientific-terms/?fbclid=IwAR3XgBRMR6I3IJsZW28MVnP-K5cou_I00yp9LqbhL0jjGuY88IGpz79VdD4

Rothan, H. A. y Byrareddy, S. N. (2020). The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak. Journal of Autoimmunity, 109, 102433. https://doi.org/10.1016/j.jaut.2020.102433

Roy, A., Kucukural, A. y Zhang, Y. (2010). I-TASSER: a unified platform for automated protein structure and function prediction. Nature Protocols, 5(4), 725-738. https://doi.org/10.1038/nprot.2010.5

RTÉ. (13 de marzo de 2020). The terminology of Covid-19: From social distancing to mitigation. https://www.rte.ie/news/coronavirus/2020/0312/1121884-covid-19-terms-delay-phase/

Rubin, G. D., Ryerson, C. J., Haramati, L. B., Sverzellati, N., Kanne, J. P., Raoof, S., Schluger, N. W., Volpi, A., Yim, J.-J., Martin, I. B. K., Anderson, D. J., Kong, C., Altes, T., Bush, A., Desai, S. R., Goldin, J., Goo, J. M., Humbert, M., Inoue, Y., … Leung, A. N. (2020). The Role of Chest Imaging in Patient Management During the COVID-19 Pandemic: A Multinational Consensus Statement From the Fleischner Society. Chest, 158(1), 106-116. https://doi.org/10.1016/j.chest.2020.04.003

Ruiz-Bravo López, A. y Jiménez Valera, M. (2020). SARS-CoV-2 y pandemia de síndrome respiratorio agudo (COVID-19). Ars Pharmaceutica, 61(2), 63-79. http://dx.doi.org/10.30827/ars.v61i2.15177

Ruizhi, Y. (27 de marzo de 2020). Unexpected digital age hazards amid the Covid-19 pandemic. ThinkChina. http://www.thinkchina.sg/unexpected-digital-age-hazards-amid-covid-19-pandemic

Saez, M., Tobias, A., Varga, D. y Barceló, M. A. (2020). Effectiveness of the measures to flatten the epidemic curve of COVID-19. The case of Spain. Science of The Total Environment, 727, 138761. https://doi.org/10.1016/j.scitotenv.2020.138761

Saif, L. J. (2020). Vaccines for COVID-19: Perspectives, Prospects, and Challenges Based on Candidate SARS, MERS, and Animal Coronavirus Vaccines. European Medical Journal. https://doi.org/10.33590/emj/200324

Sakib, N., Bhuiyan, A. K. M. I., Hossain, S., Al Mamun, F., Hosen, I., Abdullah, A. H., Sarker, Md. A., Mohiuddin, M. S., Rayhan, I., Hossain, M., Sikder, Md. T., Gozal, D., Muhit, M., Islam, S. M. S., Griffiths, M. D., Pakpour, A. H. y Mamun, M. A. (2020). Psychometric Validation of the Bangla Fear of COVID-19 Scale: Confirmatory Factor Analysis and Rasch Analysis. International Journal of Mental Health and Addiction. https://doi.org/10.1007/s11469-020-00289-x

Saladrigas, M. V. (2006). Vocabulario inglés-español de bioquímica y biología molecular (8ª y 9ª entregas). Panace@, 7(24), 199-221. https://www.tremedica.org/wp-content/uploads/n24_tradyterm-saladrigas.pdf

Saladrigas, M. V. y Calvo, J. C. (2014). Glosario EN-ES de verbos de uso frecuente en Bioquímica y Biología Molecular, fraseológico e ilustrado. Panace@, 15(40), 168-197. https://www.tremedica.org/wp-content/uploads/n40_tradyterm_Saladrigas-Calvo.pdf

Saladrigas, V. y Claros, G. (2002). Vocabulario inglés-español de bioquímica y biología molecular (1ª entrega). Panace@, 3(9-10), 13-28. https://www.tremedica.org/wp-content/uploads/n9_Pana9_tradyterm_mvsgc.pdf

Saladrigas, V., Claros, G. y González-Halphen, D. (2005). Vocabulario inglés-español de bioquímica y biología molecular (6ª entrega). Panace@, 6(19), 12-19. https://www.tremedica.org/wp-content/uploads/n19_tradyterm_saladrigas-claros-gh.pdf

Salisbury, H. (2020). When will we be well again? BMJ, 369, m2490. https://doi.org/10.1136/bmj.m2490

Sánchez-Paz, A., Mendoza, F., Encinas, T. y Muhlia, A. (24 de julio de 2020). Yo, Coronavirus: ¿A dónde vamos a parar? El Sol de México. https://www.elsoldemexico.com.mx/analisis/yo-coronavirus-a-donde-vamos-a-parar-5534188.html

Santaella-Tenorio, J. (2020). SARS-CoV-2 diagnostic testing alternatives for Latin America. Colombia Médica, 51(2), e-4272. https://doi.org/10.25100/cm.v51i2.4272

Santoni, D. y Vergni, D. (2020). In the search of potential epitopes for Wuhan seafood market pneumonia virus using high order nullomers. Journal of Immunological Methods, 481-482, 112787. https://doi.org/10.1016/j.jim.2020.112787

SARS-CoV-2 Research Using NGS. (s. f.). Recuperado el 18 de mayo de 2020 en https://www.thermofisher.com/uk/en/home/life-science/sequencing/dna-sequencing/microbial-sequencing/microbial-identification-ion-torrent-next-generation-sequencing/viral-typing/coronavirus-research.html

SARS-CoV-2 Research Using the GeneStudio S5 System. (s. f.). ThermoFisher Scientific. Recuperado el 23 de agosto de 2020 en https://www.thermofisher.com/es/es/home/life-science/sequencing/dna-sequencing/microbial-sequencing/microbial-identification-ion-torrent-next-generation-sequencing/viral-typing/coronavirus-research/genestudio-s5-system.html

Saxena, S. K. (ed.). (2020). Coronavirus Disease 2019 (COVID-19): Epidemiology, Pathogenesis, Diagnosis, and Therapeutics. Springer Singapore. https://doi.org/10.1007/978-981-15-4814-7

Scala, A., Flori, A., Spelta, A., Brugnoli, E., Cinelli, M., Quattrociocchi, W. y Pammolli, F. (2020). Between Geography and Demography: Key Interdependencies and Exit Mechanisms for COVID-19. Social Science Research Network. https://doi.org/10.2139/ssrn.3572141

Schneider, W. M., Chevillotte, M. D. y Rice, C. M. (2014). Interferon-Stimulated Genes: A Complex Web of Host Defenses. Annual Review of Immunology, 32(1), 513-545. https://doi.org/10.1146/annurev-immunol-032713-120231

Schwiegershausen, E. (8 de abril de 2020). Shelter-in-place and stay-at-home orders: What they mean. The Cut. https://www.thecut.com/article/what-does-shelter-in-place-mean.html

Scire, J., Nadeau, S., Vaughan, T., Brupbacher, G., Fuchs, S., Sommer, J., Koch, K. N., Misteli, R., Mundorff, L., Gtz, T., Eichenberger, T., Quinto, C., Savic, M., Meienberg, A., Burkard, T., Mayr, M., Meier, C. A., Widmer, A., Kuehl, R., … Stadler, T. (2020). Reproductive number of the COVID-19 epidemic in Switzerland with a focus on the Cantons of Basel-Stadt and Basel-Landschaft. Swiss Medical Weekly, 150, w20271. https://doi.org/10.4414/smw.2020.20271

Scudellari, M. (2020). The sprint to solve coronavirus protein structures — and disarm them with drugs. Nature, 581(7808), 252-255. https://doi.org/10.1038/d41586-020-01444-z

SelectScience. (25 de marzo de 2020). Proteona to develop SARS-CoV-2 neutralizing antibody. http://www.selectscience.net/industry-news/proteona-to-develop-sars-cov-2-neutralizing-antibody-against-covid-19/?artID=51028

Shang, J., Wan, Y., Luo, C., Ye, G., Geng, Q., Auerbach, A. y Li, F. (2020). Cell entry mechanisms of SARS-CoV-2. Proceedings of the National Academy of Sciences, 117(21), 11727-11734. https://doi.org/10.1073/pnas.2003138117

Shaw, A. (27 de marzo de 2020). Word of the week: Covidiot. Spectator Life. https://life.spectator.co.uk/articles/word-of-the-week-covidiot/

Shaw, A. K., White, L. A., Michalska-Smith, M., Borer, E. T., Craft, M. E., Seabloom, E. W., Snell-Rood, E. y Travisano, M. (2020). Lessons from movement ecology for the return to work: Modeling contacts and the spread of COVID-19. medRxiv. https://doi.org/10.1101/2020.05.27.20114728

Shaw, A. R. y Feinberg, M. B. (2008). 92—Vaccines. En R. R. Rich, T. A. Fleisher, W. T. Shearer, H. W. Schroeder, A. J. Frew y C. M. Weyand (eds.), Clinical Immunology (Third Edition) (pp. 1353-1382). Mosby. https://doi.org/10.1016/B978-0-323-04404-2.10092-2

Sherifat, L. (18 de febrero de 2020). Impossible to predict direction outbreak will take—WHO. Vanguard. https://www.vanguardngr.com/2020/02/impossible-to-predict-direction-outbreak-will-take-who/

Shih, G., Denyer, S., Taylor, A. y Thebault, R. (28 de enero de 2020). Coronavirus prompts CDC to expand travel warning to all of China; top U.S. health official urges Beijing to admit disease experts. Washington Post. https://www.washingtonpost.com/world/coronavirus-china-latest-updates/2020/01/27/3634db9a-40a7-11ea-aa6a-083d01b3ed18_story.html

Shirato, K., Kawase, M. y Matsuyama, S. (2018). Wild-type human coronaviruses prefer cell-surface TMPRSS2 to endosomal cathepsins for cell entry. Virology, 517, 9-15. https://doi.org/10.1016/j.virol.2017.11.012

Siddell, S. G., Walker, P. J., Lefkowitz, E. J., Mushegian, A. R., Dutilh, B. E., Harrach, B., Harrison, R. L., Junglen, S., Knowles, N. J., Kropinski, A. M., Krupovic, M., Kuhn, J. H., Nibert, M. L., Rubino, L., Sabanadzovic, S., Simmonds, P., Varsani, A., Zerbini, F. M. y Davison, A. J. (2020). Binomial nomenclature for virus species: a consultation. Archives of Virology, 165, 519-525. https://doi.org/10.1007/s00705-019-04477-6

Sieber, P., Platzer, M. y Schuster, S. (2018). The Definition of Open Reading Frame Revisited. Trends in Genetics, 34(3), 167-170. https://doi.org/10.1016/j.tig.2017.12.009

Simonelli, C., Paneroni, M., Fokom, A. G., Saleri, M., Speltoni, I., Favero, I., Garofali, F., Scalvini, S. y Vitacca, M. (2020). How the COVID-19 infection tsunami revolutionized the work of respiratory physiotherapists: An experience from Northern Italy. Monaldi Archives for Chest Disease, 90(2). https://doi.org/10.4081/monaldi.2020.1085

Singh, C. M. (13 de abril de 2020). At last a hopeful message from Wuhan known for spreading coronavirus. Daily Times. https://dailytimes.com.pk/594809/at-last-a-hopeful-message-from-wuhan-known-for-spreading-coronavirus/

Singhal, T. (2020). A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics, 87(4), 281-286. https://doi.org/10.1007/s12098-020-03263-6

Sisay, M. (2020). 3CL^pro inhibitors as a potential therapeutic option for COVID-19: Available evidence and ongoing clinical trials. Pharmacological Research, 156, 104779. https://doi.org/10.1016/j.phrs.2020.104779

Smereka, J., Ruetzler, K., Szarpak, L., Filipiak, K. J. y Jaguszewski, M. (2020). Role of mask/respirator protection against SARS-CoV-2: Anesthesia & Analgesia. Publicación electrónica previa a la edición impresa. https://doi.org/10.1213/ANE.0000000000004873

Smith, K. P., Cheng, A., Chopelas, A., DuBois-Coyne, S., Mezghani, I., Rodriguez, S., Talay, M. y Kirby, J. E. (2020). Large-scale, in-house production of viral transport media to support SARS-CoV-2 PCR testing in a multi-hospital healthcare network during the COVID-19 pandemic. Journal of Clinical Microbiology, 58(8), e00913-20. https://doi.org/10.1128/JCM.00913-20

Sociedad Argentina de Virología. (25 de marzo de 2020). Informe SARS-CoV-2. https://nanobiotec.conicet.gov.ar/wp-content/uploads/sites/33/2020/03/Informe-SAV-AAM-SARS-CoV-2-2020.03.25.pdf

Sohrabi, C., Alsafi, Z., O’Neill, N., Khan, M., Kerwan, A., Al-Jabir, A., Iosifidis, C. y Agha, R. (2020). World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19). International Journal of Surgery, 76, 71-76. https://doi.org/10.1016/j.ijsu.2020.02.034

Song, W., Gui, M., Wang, X. y Xiang, Y. (2018). Cryo-EM structure of the SARS coronavirus spike glycoprotein in complex with its host cell receptor ACE2. PLOS Pathogens, 14(8), e1007236. https://doi.org/10.1371/journal.ppat.1007236

Soonsawad, S., Tongsawang, N. y Nuntnarumit, P. (2016). Heated Humidified High-Flow Nasal Cannula for Weaning from Continuous Positive Airway Pressure in Preterm Infants: A Randomized Controlled Trial. Neonatology, 110(3), 204-209. https://doi.org/10.1159/000446063

Sosa-Medellín, M. Á., Luviano-García, J. A., Sosa-Medellín, M. Á. y Luviano-García, J. A. (2018). Terapia de reemplazo renal continua. Conceptos, indicaciones y aspectos básicos de su programación. Medicina interna de México, 34(2), 288-298. https://doi.org/10.24245/mim.v34i2.1652

South, A. M., Brady, T. M. y Flynn, J. T. (2020). ACE2 (Angiotensin-Converting Enzyme 2), COVID-19, and ACE Inhibitor and Ang II (Angiotensin II) Receptor Blocker Use During the Pandemic: The Pediatric Perspective. Hypertension, 76(1), 16-22. https://doi.org/10.1161/HYPERTENSIONAHA.120.15291

Stahlmann, R. y Lode, H. (2020). Medication for COVID-19—An overview of approaches currently under study. Deutsches Ärzteblatt International, 117, 213-219. https://doi.org/10.3238/arztebl.2020.0213

Standaert, M. (9 de febrero de 2020). China virus funeral order fuels upset as death toll rises. Al Jazeera. https://www.aljazeera.com/news/2020/02/china-virus-funeral-order-fuels-upset-death-toll-exceeds-sars-200209010139644.html

Stanford, W. L., Epp, T., Reid, T. y Rossant, J. (2006). Gene trapping in embryonic stem cells. Methods in Enzymology, 420, 136-162. https://doi.org/10.1016/S0076-6879(06)20008-9

Stier, A., Berman, M. y Bettencourt, L. (2020). COVID-19 Attack Rate Increases with City Size. medRxiv. https://doi.org/10.1101/2020.03.22.20041004

Street, M. E. (2020). HMGB1: A Possible Crucial Therapeutic Target for COVID-19? Hormone Research in Paediatrics, 93(2), 73-75. https://doi.org/10.1159/000508291

Sudan, P., Goswami, M. y Babu, A. M. (2020). Novel Coronavirus (COVID-19)-A Critical Review. International Journal of Research in Pharmaceutical Sciences, 11(SPL1), 43-47. https://doi.org/10.26452/ijrps.v11iSPL1.2112

Summit Medical Group. (2 de abril de 2020). Must-Know Covid-19 Vocabulary. Living Well. https://www.summitmedicalgroup.com/news/living-well/must-know-covid-19-vocabulary/

Sun, P., Lu, X., Xu, C., Sun, W. y Pan, B. (2020). Understanding of COVID‐19 based on current evidence. Journal of Medical Virology, 92(6), 548-551. https://doi.org/10.1002/jmv.25722

Surjit, M. y Lal, S. K. (2008). The SARS-CoV nucleocapsid protein: A protein with multifarious activities. Infection, Genetics and Evolution, 8(4), 397-405. https://doi.org/10.1016/j.meegid.2007.07.004

Sweeny, K. (2002). Technology Trends in Drug Discovery and Development: Implications for the Development of the Pharmaceutical Industry in Australia. Center for Strategic Economic Studies (Victoria University of Technology). http://vuir.vu.edu.au/15923/1/15923.pdf

Swiss Institute of Bioinformatics (SIB). (s. f.). Coronaviridae. En ViralZone. Recuperado el 13 de abril de 2020 en https://viralzone.expasy.org/30?outline=all_by_protein

Swiss Institute of Bioinformatics. (s. f.). Ribosomal frameshifting. En ViralZone. Recuperado el 13 de abril de 2020 en https://viralzone.expasy.org/860?outline=all_by_protein

Syed, M. (4 de mayo de 2020). I challenge the online ‘experts’ so critical of No 10 on coronavirus: Tell us, has Sweden got it right or wrong? The Sunday Times. https://www.thetimes.co.uk/article/i-challenge-the-online-experts-so-critical-of-no-10-on-coronavirus-tell-us-has-sweden-got-it-right-or-wrong-xk6nlpjfx

Talarico, L. B. (2008). La entrada del virus dengue a la célula como un potencial blanco antiviral: estudio de polisacáridos sulfatados como antivirales. Química Viva, 7(2). http://www.quimicaviva.qb.fcen.uba.ar/v7n2/talarico.pdf

Tami, M. C. (1999). Evaluación de vacunas peptídicas contra el virus de la fiebre aftosa en bovinos: Aislamiento y caracterización de mutantes de escape [Tesis doctoral. Facultad de Ciencias Exactas y Naturales. Universidad de Buenos Aires]. http://digital.bl.fcen.uba.ar/Download/Tesis/Tesis_3184_Tami.pdf

Tang, T., Bidon, M., Jaimes, J. A., Whittaker, G. R. y Daniel, S. (2020). Coronavirus membrane fusion mechanism offers a potential target for antiviral development. Antiviral Research, 178, 104792. https://doi.org/10.1016/j.antiviral.2020.104792

Tang, Y.-W. y Stratton, C. W. (eds.). (2006). Advanced techniques in diagnostic microbiology. Springer. https://doi.org/10.1007/0-387-32892-0

Tatum, S. (20 de marzo de 2020). Amid shortage, Pence says millions of masks available «now» for hospitals to buy. ABC News. https://abcnews.go.com/Politics/amid-shortage-pence-millions-masks-now-hospitals-buy/story?id=69693065

Te Velthuis, A. J. W., Van den Worm, S. H. E. y Snijder, E. J. (2012). The SARS-coronavirus nsp7+nsp8 complex is a unique multimeric RNA polymerase capable of both de novo initiation and primer extension. Nucleic Acids Research, 40(4), 1737-1747. https://doi.org/10.1093/nar/gkr893

Templeton, D. M., Schwenk, M., Klein, R. y Duffus, J. H. (2012). IUPAC glossary of terms used in immunotoxicology (IUPAC Recommendations 2012). Pure and Applied Chemistry, 84(5), 1113-1295. https://doi.org/10.1351/PAC-REC-11-06-03

Termcat. (2020) Termes del coronavirus. https://www.termcat.cat/ca/diccionaris-en-linia/286

The Henry J. Kaiser Family Foundation. (s. f.). Coronavirus (COVID-19) Outbreak Glossary. Recuperado el 18 de marzo de 2020 en https://www.kff.org/glossary/covid-19-outbreak-glossary/

The New York Times Morning Briefing. (12 de abril de 2020). Coronavirus Live Updates: Risks of Reopening Economy Weighed. The New York Times. https://www.nytimes.com/2020/04/12/us/coronavirus-updates.html

Thi Nhu Thao, T., Labroussaa, F., Ebert, N., V’kovski, P., Stalder, H., Portmann, J., Kelly, J., Steiner, S., Holwerda, M., Kratzel, A., Gultom, M., Schmied, K., Laloli, L., Hüsser, L., Wider, M., Pfaender, S., Hirt, D., Cippà, V., Crespo-Pomar, S., … Thiel, V. (2020). Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 582(7813), 561-565. https://doi.org/10.1038/s41586-020-2294-9

Thrusfield, M. V. (2007). Veterinary epidemiology (3ª ed., reimpresión con actualizaciones). Blackwell Science.

Tiger force will help accelerate efforts of local admin in its relief activities. (4 de mayo de 2020). Radio Pakistan. http://www.radio.gov.pk/04-05-2020/tiger-force-will-help-accelerate-efforts-of-local-admin-in-its-relief-activities

Tok, T. T. y Tatar, G. (2017). Structures and Functions of Coronavirus Proteins: Molecular Modeling of Viral Nucleoprotein. International Journal of Virology & Infectious Diseases, 2(1), 001-007. https://www.scireslit.com/Virology/IJVID-ID13.pdf

Ton, A. N., Jethwa, T., Waters, K., Speicher, L. L. y Francis, D. (2020). COVID-19 drive through testing: An effective strategy for conserving personal protective equipment. American Journal of Infection Control, 48(6), 731-732. https://doi.org/10.1016/j.ajic.2020.04.010

Tong, T. R. (2009a). Therapies for coronaviruses. Part I of II – viral entry inhibitors. Expert Opinion on Therapeutic Patents, 19(3), 357-367. https://doi.org/10.1517/13543770802609384

Tong, T. R. (2009b). Therapies for coronaviruses. Part 2: Inhibitors of intracellular life cycle. Expert Opinion on Therapeutic Patents, 19(4), 415-431. https://doi.org/10.1517/13543770802600698

Tortorici, M. A. y Veesler, D. (2019). Chapter Four—Structural insights into coronavirus entry. En F. A. Rey (ed.), Advances in Virus Research (Vol. 105, pp. 93-116). Academic Press. https://doi.org/10.1016/bs.aivir.2019.08.002

Toussaint, K. (18 de marzo de 2020). Why drive-through testing is such an important tool in the coronavirus fight. Fast Company. https://www.fastcompany.com/90478596/why-drive-through-testing-is-such-an-important-tool-in-the-coronavirus-fight

Trabsky, M. y Hempton, C. (9 de septiembre de 2020). «Died from» or «died with» COVID-19? We need a transparent approach to counting coronavirus deaths. The Conversation. http://theconversation.com/died-from-or-died-with-covid-19-we-need-a-transparent-approach-to-counting-coronavirus-deaths-145438

Trapotsis, A. (31 de marzo de 2020). Do you know the difference in laboratory biosafety levels 1, 2, 3 & 4? Consolidated Sterilizer Systems. https://consteril.com/biosafety-levels-difference/

Tu, Y.-F., Chien, C.-S., Yarmishyn, A. A., Lin, Y.-Y., Luo, Y.-H., Lin, Y.-T., Lai, W.-Y., Yang, D.-M., Chou, S.-J., Yang, Y.-P., Wang, M.-L. y Chiou, S.-H. (2020). A Review of SARS-CoV-2 and the Ongoing Clinical Trials. International Journal of Molecular Sciences, 21(7), 2657. https://doi.org/10.3390/ijms21072657

Tufekci, Z. (22 de febrero de 2020). How the Coronavirus Revealed Authoritarianism’s Fatal Flaw. The Atlantic. https://www.theatlantic.com/technology/archive/2020/02/coronavirus-and-blindness-authoritarianism/606922/

3. S. Department of Health and Human Services (USDHHS). (2012). Principles of Epidemiology in Public Health Practice. An Introduction to Applied Epidemiology and Biostatistics (3.ª ed.). https://www.cdc.gov/csels/dsepd/ss1978/SS1978.pdf
4. S. Department of Health and Human Services, Food and Drug Administration, Office of the Commissioner, Office of the Chief Scientist y Office of Counterterrorism and Emerging Threats. (2017). Emergency Use Authorization of Medical Products and Related Authorities. Guidance for Industry and Other Stakeholders. https://www.fda.gov/media/97321/download
5. S. Department of Transportation. (2006). Transporting Infectious Substances Safely. https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/Transporting_Infectious_Substances_brochure.pdf
6. S. Food and Drug Administration. (2020). N95 Respirators and Surgical Masks (Face Masks). Recuperado el 5 de abril de 2020 en https://www.fda.gov/medical-devices/personal-protective-equipment-infection-control/n95-respirators-and-surgical-masks-face-masks
7. S. Food and Drug Administration. (s. f.). Emergency Use Authorization. Emergency Use Authorization (EUA) information, and list of all current EUAs. Recuperado el 16 de octubre de 2020 en https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization.

Udugama, B., Kadhiresan, P., Kozlowski, H. N., Malekjahani, A., Osborne, M., Li, V. Y. C., Chen, H., Mubareka, S., Gubbay, J. B. y Chan, W. C. W. (2020). Diagnosing COVID-19: The Disease and Tools for Detection. ACS Nano, 14(4), 3822-3835. https://doi.org/10.1021/acsnano.0c02624

Umer, F., Haji, Z. y Zafar, K. (2020). Role of respirators in controlling the spread of novel coronavirus (COVID‐19) amongst dental healthcare providers: A review. International Endodontic Journal, 53(8), 1062-1067. https://doi.org/10.1111/iej.13313

University of Basel. (29 de octubre de 2020). Spread of a novel SARS-CoV-2 variant across Europe in summer 2020. https://www.unibas.ch/en/News-Events/News/Uni-Research/Spread-of-a-novel-SARS-CoV-2-variant-across-Europe-in-summer-2020.html

University of Rochester. (s. f.). COVID-19 Terminology and Definitions. Recuperado el 13 de abril de 2020 en https://www.rochester.edu/coronavirus-update/terminology/

Usul Afsar, C. (2020). 2019-nCoV-SARS-CoV-2 (COVID-19) infection: Crucıalıty of Furın and relevance wıth cancer. Medical Hypotheses, 140, 109770. https://doi.org/10.1016/j.mehy.2020.109770

Utsumi, M., Makimoto, K., Quroshi, N. y Ashida, N. (2010). Types of infectious outbreaks and their impact in elderly care facilities: A review of the literature. Age and Ageing, 39(3), 299-305. https://doi.org/10.1093/ageing/afq029

Vaishya, R., Haleem, A., Vaish, A. y Javaid, M. (2020). Emerging Technologies to Combat the COVID-19 Pandemic. Journal of Clinical and Experimental Hepatology, 10(4), 409-411. https://doi.org/10.1016/j.jceh.2020.04.019

Van der Most, R. G., Bredenbeek, P. J. y Spaan, W. J. (1991). A domain at the 3’ end of the polymerase gene is essential for encapsidation of coronavirus defective interfering RNAs. Journal of Virology, 65(6), 3219-3226. https://doi.org/10.1128/JVI.65.6.3219-3226.1991

Van Doremalen, N., Bushmaker, T., Morris, D. H., Holbrook, M. G., Gamble, A., Williamson, B. N., Tamin, A., Harcourt, J. L., Thornburg, N. J., Gerber, S. I., Lloyd-Smith, J. O., de Wit, E. y Munster, V. J. (17 de marzo de 2020). Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1 [Carta al director]. New England Journal of Medicine. https://doi.org/10.1056/NEJMc2004973

Van Hemert, M. J., Van den Worm, S. H. E., Knoops, K., Mommaas, A. M., Gorbalenya, A. E. y Snijder, E. J. (2008). SARS-Coronavirus Replication/Transcription Complexes Are Membrane-Protected and Need a Host Factor for Activity In Vitro. PLoS Pathogens, 4(5), e1000054. https://doi.org/10.1371/journal.ppat.1000054

Vanden Eynde, J. J. (2020). COVID-19: A Brief Overview of the Discovery Clinical Trial. Pharmaceuticals, 13(4), 65. https://doi.org/10.3390/ph13040065

Vardhana, S. A. y Wolchok, J. D. (2020). The many faces of the anti-COVID immune response. Journal of Experimental Medicine, 217(6), e20200678. https://doi.org/10.1084/jem.20200678

Varela Vila, T., Sánchez Trigo, E. y Marta Rodríguez, V. (2012). Vocabulario inglés-español de productos de apoyo utilizados en terapia ocupacional para personas con enfermedades neuromusculares. Panace@, 13(35), 69-90. https://www.tremedica.org/wp-content/uploads/n35-tradyterm-Vila_et-al.pdf

Varshney, V. (22 de mayo de 2020). International Day for Biological Diversity 2020: Why viruses are necessary. DowntoEarth. https://www.downtoearth.org.in/blog/science-technology/international-day-for-biological-diversity-2020-why-viruses-are-necessary-71305

Vásquez-Hoyos, P., Arias-Fernández, D. A., Barrios-Marenco, A., Álvarez-Fonseca, Y. C. y Soler-Rincón, P. J. (2018). Experience in the use of high flow nasal cannula in a neonatal intensive care unit in a 2,600 meters above sea level hospital. Revista Mexicana de Pediatría, 85(2), 60-65. https://www.medigraphic.com/cgi-bin/new/resumenI.cgi?IDARTICULO=79711

Vattay, G. (2020). Predicting the ultimate outcome of the COVID-19 outbreak in Italy. arXiv. http://arxiv.org/abs/2003.07912

Vavougios, G. D. (2020). A data-driven hypothesis on the epigenetic dysregulation of host metabolism by SARS coronaviral infection: Potential implications for the SARS-CoV-2 modus operandi. Medical Hypotheses, 140, 109759. https://doi.org/10.1016/j.mehy.2020.109759

Vázquez-Vizoso, F. L., García García, M. J., Abraira García, L. y Del Campo Pérez, V. (2015). Uso de mascarillas quirúrgicas y máscaras FFP en las precauciones de aislamiento de los centros sanitarios. Sociedade Galega de Medicina Preventiva (SOGAMP). http://files.sogamp.webnode.es/200000031-aa453ab3b3/GuiaMascarasSOGAMP_vES%20-281-29.pdf

Venter, M. y Richter, K. (2020). Towards effective diagnostic assays for COVID-19: A review. Journal of Clinical Pathology, 73(7), 370-377. https://doi.org/10.1136/jclinpath-2020-206685

Villareal, M. (1 de febrero de 2020). DOT Urges to Take Necessary Measures vs. 2019-nCoV Novel Coronavirus. Out of Town Blog. https://outoftownblog.com/dot-urges-to-take-necessary-measures-vs-2019-ncov-novel-coronavirus/

Villeneuve, M. y Hinnant, L. (8 de abril de 2020). Even as virus deaths mount, governments eye exit strategies. The Columbian. https://www.columbian.com/news/2020/apr/08/even-as-virus-deaths-mount-governments-eye-exit-strategies/

VOA News. (23 de mayo de 2020). ‘Superspreader’ Events May Be Responsible for 80% of COVID Infections. Voice of America. https://www.voanews.com/covid-19-pandemic/superspreader-events-may-be-responsible-80-covid-infections

Wahbeh, A., Nasralah, T., Al-Ramahi, M. y El-Gayar, O. (2020). Mining Physicians’ Opinions on Social Media to Obtain Insights Into COVID-19: Mixed Methods Analysis. JMIR Public Health and Surveillance, 6(2), e19276. https://doi.org/10.2196/19276

Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T. y Veesler, D. (2020). Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell, 0(0). https://doi.org/10.1016/j.cell.2020.02.058

Wan, Y., Shang, J., Graham, R., Baric, R. S. y Li, F. (2020). Receptor Recognition by the Novel Coronavirus from Wuhan: An Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Journal of Virology, 94(7), e00127-20. https://doi.org/10.1128/JVI.00127-20

Wang, C., Li, W., Drabek, D., Okba, N. M. A., Van Haperen, R., Osterhaus, A. D. M. E., Van Kuppeveld, F. J. M., Haagmans, B. L., Grosveld, F. y Bosch, B.-J. (2020). A human monoclonal antibody blocking SARS-CoV-2 infection. Nature Communications, 11(1), 2251. https://doi.org/10.1038/s41467-020-16256-y

Wang, F., Kream, R. M. y Stefano, G. B. (2020). An Evidence Based Perspective on mRNA-SARS-CoV-2 Vaccine Development. Medical Science Monitor, 26, e924700. https://doi.org/10.12659/MSM.924700

Wang, J., Cai, K., Zhang, R., He, X., Shen, X., Liu, J., Xu, J., Qiu, F., Lei, W., Wang, J., Li, X., Gao, Y., Jiang, Y., Xu, W. y Ma, X. (2020). Novel One-Step Single-Tube Nested Quantitative Real-Time PCR Assay for Highly Sensitive Detection of SARS-CoV-2. Analytical Chemistry, 92(13), 9399-9404. https://doi.org/10.1021/acs.analchem.0c01884

Wang, L., Wang, Y., Ye, D. y Liu, Q. (2020). Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. International Journal of Antimicrobial Agents, 55(6), 105948. https://doi.org/10.1016/j.ijantimicag.2020.105948

Wang, N., Shang, J., Jiang, S. y Du, L. (2020). Subunit Vaccines Against Emerging Pathogenic Human Coronaviruses. Frontiers in Microbiology, 11, 298. https://doi.org/10.3389/fmicb.2020.00298

Wang, Q., Zhang, Y., Wu, L., Niu, S., Song, C., Zhang, Z., Lu, G., Qiao, C., Hu, Y., Yuen, K.-Y., Wang, Q., Zhou, H., Yan, J. y Qi, J. (2020). Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2. Cell, 181, 1-11. https://doi.org/10.1016/j.cell.2020.03.045

Washburn, L. (s. f.). Coronavirus: How NJ hospitals are preparing for possible epidemic. northjersey.com. https://www.northjersey.com/story/news/health/2020/02/25/coronavirus-how-nj-hospitals-preparing-possible-epidemic/4858668002/

Wells, C. R., Fitzpatrick, M. C., Sah, P., Shoukat, A., Pandey, A., El-Sayed, A. M., Singer, B. H., Moghadas, S. M. y Galvani, A. P. (2020). Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA. The Lancet Infectious Diseases, 20(10), 1123-1125. https://doi.org/10.1016/S1473-3099(20)30315-7

Wentworth, D. E., Gillim-Ross, L., Espina, N. y Bernard, K. A. (2004). Mice Susceptible to SARS Coronavirus. Emerging Infectious Diseases, 10(7), 1293-1296. https://doi.org/10.3201/eid1007.031119

‘What Are the Symptoms?’ ‘What Should I Do if I Feel Sick?’ and Other Coronavirus Questions. (9 de septiembre de 2020). The New York Times. https://www.nytimes.com/article/symptoms-coronavirus.html

What is a cross infection?. (4 de febrero de 2019). Advanced Tissue. https://advancedtissue.com/2019/02/what-is-a-cross-infection/

Whitworth, J. (2020). COVID-19: A fast evolving pandemic. Transactions of The Royal Society of Tropical Medicine and Hygiene, 114(4), 241-248. https://doi.org/10.1093/trstmh/traa025

Wilson, D. E. y Chosewood, L. C. (eds.). (2009). Biosafety in Microbiological and Biomedical Laboratories (5.ª ed.). CDC/U. S. Department of Health and Human Services. https://www.cdc.gov/labs/pdf/CDC-BiosafetyMicrobiologicalBiomedicalLaboratories-2009-P.PDF

Winsa, P. (6 de mayo de 2020). The proportion of COVID-19 deaths in long-term care was measured in 14 countries. Canada had the worst record. The Star. https://www.thestar.com/news/gta/2020/05/06/the-proportion-of-covid-19-deaths-in-long-term-care-was-measured-in-14-countries-canada-had-the-worst-record.html

Winton, N. (26 de febrero de 2020). Geneva Auto Show Will Open, Organizers Say, Despite Virus Spread To Switzerland. Forbes. https://www.forbes.com/sites/neilwinton/2020/02/26/geneva-auto-show-will-open-as-planned-organizers-say-despite-virus-spread-to-switzerland/

Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., Hoelscher, M., Bleicker, T., Brünink, S., Schneider, J., Ehmann, R., Zwirglmaier, K., Drosten, C. y Wendtner, C. (2020). Virological assessment of hospitalized patients with COVID-2019. Nature. https://doi.org/10.1038/s41586-020-2196-x

Wu, C., Liu, Y., Yang, Y., Zhang, P., Zhong, W., Wang, Y., Wang, Q., Xu, Y., Li, M., Li, X., Zheng, M., Chen, L. y Li, H. (2020). Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods. Acta Pharmaceutica Sinica B. https://doi.org/10.1016/j.apsb.2020.02.008

Wu, D., Wu, T., Liu, Q. y Yang, Z. (2020). The SARS-CoV-2 outbreak: What we know. International Journal of Infectious Diseases, 94, 44-48. https://doi.org/10.1016/j.ijid.2020.03.004

Wu, J. T., Leung, K., Bushman, M., Kishore, N., Niehus, R., de Salazar, P. M., Cowling, B. J., Lipsitch, M. y Leung, G. M. (2020). Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China. Nature Medicine, 26(4), 506-510. https://doi.org/10.1038/s41591-020-0822-7

Wu, J., Pan, J., Teng, D., Xu, X., Feng, J. y Chen, Y.-C. (2020). Interpretation of CT signs of 2019 novel coronavirus (COVID-19) pneumonia. European Radiology, 30(10), 5455-5462. https://doi.org/10.1007/s00330-020-06915-5

Xie, H.-T., Jiang, S.-Y., Xu, K.-K., Liu, X., Xu, B., Wang, L. y Zhang, M.-C. (2020). SARS-CoV-2 in the ocular surface of COVID-19 patients. Eye and Vision, 7(1), 23. https://doi.org/10.1186/s40662-020-00189-0

Yamada, Y. y Liu, D. X. (2009). Proteolytic Activation of the Spike Protein at a Novel RRRR/S Motif Is Implicated in Furin-Dependent Entry, Syncytium Formation, and Infectivity of Coronavirus Infectious Bronchitis Virus in Cultured Cells. Journal of Virology, 83(17), 8744-8758. https://doi.org/10.1128/JVI.00613-09

Yang, C. L., Qiu, Y. K., Zeng, Y. K., Jiang, M., Fan, H. R. y Zhang, Z. M. (2020). Coronavirus disease 2019: a clinical review. European Review for Medical and Pharmacological Sciences, 24(8), 4585-4596. https://doi.org/10.26355/eurrev_202004_21045

Yang, C.-W., Lee, Y.-Z., Hsu, H.-Y., Shih, C., Chao, Y.-S., Chang, H.-Y. y Lee, S.-J. (2017). Targeting Coronaviral Replication and Cellular JAK2 Mediated Dominant NF-κB Activation for Comprehensive and Ultimate Inhibition of Coronaviral Activity. Scientific Reports, 7(1), 4105. https://doi.org/10.1038/s41598-017-04203-9

Yang, J., Yan, R., Roy, A., Xu, D., Poisson, J. y Zhang, Y. (2015). The I-TASSER Suite: Protein structure and function prediction. Nature Methods, 12(1), 7-8. https://doi.org/10.1038/nmeth.3213

Yang, N. y Shen, H.-M. (2020). Targeting the Endocytic Pathway and Autophagy Process as a Novel Therapeutic Strategy in COVID-19. International Journal of Biological Sciences, 16(10), 1724-1731. https://doi.org/10.7150/ijbs.45498

Yang, Q., Liu, Q., Xu, H., Lu, H., Liu, S. y Li, H. (2020). Imaging of coronavirus disease 2019: A Chinese expert consensus statement. European Journal of Radiology, 127, 109008. https://doi.org/10.1016/j.ejrad.2020.109008

Yin, C. (2020). Genotyping coronavirus SARS-CoV-2: Methods and implications. Genomics, 112(5), 3588-3596. https://doi.org/10.1016/j.ygeno.2020.04.016

Yoon, J.-Y. y Kim, B. (2012). Lab-on-a-Chip Pathogen Sensors for Food Safety. Sensors, 12(8), 10713-10741. https://doi.org/10.3390/s120810713

Zayet, S., N’dri Juliette, K.-O., Royer, P.-Y., Toko, L., Gendrin, V. y Klopfenstein, T. (2020). Coronavirus disease 2019: New things to know! [Carta al director]. Journal of Medical Virology, 92, 1767-1768. https://doi.org/10.1002/jmv.25874

Zeltner, B. (16 de marzo de 2020). Coronavirus glossary: Your guide to the language of a pandemic. Cleveland.com. https://www.cleveland.com/metro/2020/03/coronavirus-glossary-your-guide-to-the-language-of-a-pandemic.html

Zhang Lab, University of Michigan. (s. f.). Genome-wide structure and function modeling of SARS-CoV-2. https://zhanglab.ccmb.med.umich.edu/COVID-19/

Zhang Lab, University of Michigan. (s. f.). I-TASSER Protein Structure and Function Predictions [Programa informático]. https://zhanglab.ccmb.med.umich.edu/I-TASSER/

Zhang, H., Penninger, J. M., Li, Y., Zhong, N. y Slutsky, A. S. (2020). Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Medicine, 46(4), 586-590. https://doi.org/10.1007/s00134-020-05985-9

Zhang, J., Xie, Y., Liao, Z., Pang, G., Verjans, J., Li, W., Sun, Z., He, J., Li, Y., Shen, C. y Xia, Y. (2020). Viral Pneumonia Screening on Chest X-ray Images Using Confidence-Aware Anomaly Detection. arXiv. http://arxiv.org/abs/2003.12338

Zhang, W. Y., Yu, L. Q., Huang, J. A. y Zeng, D. X. (2020). Prolonged Viral RNA Shedding Duration in COVID-19. American Journal of Therapeutics, 10.1097/MJT.0000000000001200. Publicación anticipada en línea. https://doi.org/10.1097/MJT.0000000000001200

Zhang, W., Cheng, W., Luo, L., Ma, Y., Xu, C., Qin, P. y Zhang, Z. (2020). Secondary Transmission of Coronavirus Disease from Presymptomatic Persons, China. Emerging infectious diseases, 26(8), 1924–1926. https://doi.org/10.3201/eid2608.201142

Zhang, Y. (2008). I-TASSER server for protein 3D structure prediction. BMC Bioinformatics, 9, 40. https://doi.org/10.1186/1471-2105-9-40

Zhang, Y. y Barklis, E. (1995). Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation. Journal of Virology, 69(9), 5716-5722. https://doi.org/10.1128/JVI.69.9.5716-5722.1995

Zhao, N., Zhou, Z.-L., Wu, L., Zhang, X.-D., Han, S.-B., Bao, H.-J., Shu, Y. y Shu, X.-G. (2020). An update on the status of COVID-19: A comprehensive review. European Review for Medical and Pharmacological Sciences, 24(8), 4597-4606. https://doi.org/10.26355/eurrev_202004_21046

Zheng, Z., Peng, F., Xu, B., Zhao, J., Liu, H., Peng, J., Li, Q., Jiang, C., Zhou, Y., Liu, S., Ye, C., Zhang, P., Xing, Y., Guo, H. y Tang, W. (2020). Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection, 81(2), E16-E25. https://doi.org/10.1016/j.jinf.2020.04.021

Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W. y Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6(1), 14. https://doi.org/10.1038/s41421-020-0153-3

Zhou, Yadi, Hou, Y., Shen, J., Huang, Y., Martin, W. y Cheng, F. (2020). Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2. Cell Discovery, 6(1), 1-18. https://doi.org/10.1038/s41421-020-0153-3

Zhou, Yifan, Li, W., Wang, D., Mao, L., Jin, H., Li, Y., Hong, C., Chen, S., Chang, J., He, Q., Wang, M. y Hu, B. (2020). Clinical time course of COVID-19, its neurological manifestation and some thoughts on its management. Stroke and Vascular Neurology, 5(2), 177-179. https://doi.org/10.1136/svn-2020-000398

Züst, R. (2008). Reverse genetic analysis of coronavirus replication [Tesis doctoral. Universität Zürich]. https://doi.org/10.5167/UZH-163822